hg_168075.1

Basic information about the TSS

---

TSS ID: hg_168075.1 Species: human Chr: chr17		Start: 75393753 End: 75393769 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000578961.5 Distance: -34 GeneID: 2885 HGNC/MGI_ID: HGNC:4566 UniProt_ID: J3QRL5

Gene_name: growth factor receptor bound protein 2 Gene_symbol: GRB2 Gene_synonyms: NCKAP2 Gene_source: HGNC:4566

TATA-Box annotation

---

Distance to TSS:	11917
Nearest PromoterID:	NM_002086
Entrez ID:	2885
Nearest Unigene:	Hs.444356
Nearest Refseq:	NM_002086
Nearest Ensembl:	ENSG00000177885
Gene Name:	growth factor receptor bound protein 2
Gene Alias:	ASH|EGFRBP-GRB2|Grb3-3|MST084|MSTP084|NCKAP2
Gene Description:	growth factor receptor bound protein 2
Gene Type:	protein-coding
CpG%:	0.04
GC%:	0.646766
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@GRB2 p2@GRB2 p3@GRB2 p4@GRB2 p5@GRB2 p6@GRB2 p7@GRB2 p8@GRB2
Sample		p1@GRB2	p2@GRB2	p3@GRB2	p4@GRB2	p5@GRB2	p6@GRB2	p7@GRB2	p8@GRB2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	84.16	1.56	2.73	1.95	0.19	0.00	0.39	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	91.04	1.82	3.03	2.23	0.00	0.00	0.00	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	76.97	1.35	1.93	2.12	0.39	0.19	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	70.48	1.66	4.99	2.29	0.21	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	82.56	2.02	4.95	2.25	0.45	0.00	0.22	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	70.35	2.13	3.88	3.10	0.78	0.00	0.00	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	75.17	3.05	3.70	2.40	0.22	0.22	0.00	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	66.85	1.45	2.66	0.48	0.48	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	71.81	1.92	3.21	0.21	0.21	0.00	0.00	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	48.11	4.06	4.64	0.58	0.58	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	47.70	3.23	4.85	2.43	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	44.72	3.25	3.25	2.03	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	33.37	8.06	0.81	0.48	0.16	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	26.46	7.67	0.90	1.20	0.45	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	25.03	6.59	1.32	1.54	0.22	0.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	21.63	4.78	0.00	0.50	0.00	0.00	0.00	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	20.09	5.02	0.87	0.87	0.00	0.00	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	18.56	4.22	0.84	0.42	0.00	0.00	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	25.06	2.67	1.60	0.53	0.00	0.00	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	22.57	5.72	0.60	0.75	0.15	0.00	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	27.67	7.75	0.94	1.20	0.13	0.00	0.27	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	23.13	7.25	0.69	0.69	0.00	0.00	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	28.05	5.43	0.65	0.39	0.13	0.00	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	26.21	6.79	0.00	0.97	0.24	0.00	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	26.83	5.16	0.26	0.52	0.00	0.00	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	22.47	6.33	0.00	1.27	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	23.08	7.14	1.10	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	32.30	5.42	0.47	1.18	0.00	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	27.46	5.98	0.32	0.81	0.00	0.00	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	24.25	6.33	0.54	0.72	0.00	0.00	0.18	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	25.12	3.35	0.42	1.05	0.00	0.00	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	22.08	8.79	0.78	0.59	0.00	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	24.27	8.23	0.63	0.84	0.42	0.21	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	29.52	7.42	0.49	1.48	0.16	0.16	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	24.12	5.42	0.75	0.56	0.19	0.19	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	27.40	4.22	0.19	0.19	0.00	0.19	0.19	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	29.02	4.70	0.41	1.64	0.00	0.00	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	24.78	5.04	0.40	0.81	0.20	0.00	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	25.12	4.32	0.54	0.27	0.54	0.00	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	24.73	4.08	0.72	0.72	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	28.70	5.65	0.71	0.24	0.00	0.00	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	29.13	6.44	0.29	1.17	0.15	0.29	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	26.15	4.22	1.27	0.42	0.21	0.00	0.21	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	34.09	5.24	0.52	0.35	0.17	0.00	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	29.31	5.62	0.60	0.40	0.40	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	28.62	4.89	1.63	0.70	0.23	0.00	0.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	30.71	3.12	0.24	0.72	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	23.84	6.86	0.00	0.89	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	29.92	3.11	0.72	1.20	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	32.55	5.46	1.82	0.40	0.40	0.00	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	29.31	4.30	0.61	1.43	0.41	0.00	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	36.69	4.00	0.67	0.67	0.00	0.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	69.96	0.00	13.99	0.00	0.00	0.00	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	29.10	3.90	0.35	0.00	0.35	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	30.82	1.66	0.33	0.33	0.66	0.00	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	61.24	8.39	0.84	0.00	0.84	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	41.33	7.35	0.46	2.30	0.92	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	25.28	2.92	1.30	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	21.52	0.96	1.61	0.00	0.64	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	30.49	2.83	0.63	1.57	0.63	0.00	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	29.61	2.12	0.00	0.00	0.71	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	21.87	1.68	0.56	0.00	0.56	0.00	0.00	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	31.05	5.57	0.00	0.80	0.00	0.00	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	25.14	8.15	0.68	1.02	0.34	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	32.49	2.60	1.62	0.32	0.32	0.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	28.40	2.48	1.06	0.35	0.35	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	96.98	16.16	0.00	16.16	0.00	0.00	0.00	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	157.95	31.59	0.00	7.90	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	35.10	3.41	0.49	0.00	0.00	0.00	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	26.28	4.96	1.98	0.99	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	39.41	1.88	1.41	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	33.45	7.29	1.32	0.33	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	33.41	5.57	1.24	0.00	0.31	0.31	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	34.85	6.42	1.22	0.00	0.00	0.00	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	43.24	3.01	2.22	0.95	0.32	0.16	0.00	0.63
Adipocyte - breast, donor2	11327-117E4	49.41	4.17	1.76	4.49	0.96	0.16	0.32	0.00
Adipocyte - omental, donor1	11473-119C6	50.76	7.76	2.29	2.54	0.00	0.13	0.13	0.51
Adipocyte - omental, donor2	11474-119C7	43.35	8.97	1.49	1.49	0.00	0.00	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	36.17	3.01	0.67	2.34	1.00	0.33	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	47.85	3.83	0.64	1.28	0.64	0.00	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	26.39	4.40	0.00	2.20	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	46.52	2.71	2.26	0.90	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	39.97	2.78	0.52	0.70	0.17	0.17	0.00	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	72.95	8.80	3.13	2.35	0.20	0.59	0.00	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	61.00	4.89	2.57	0.51	0.26	0.00	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	60.49	7.81	1.12	0.84	0.00	0.00	0.28	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	68.77	2.35	1.76	2.35	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	99.01	13.11	4.83	16.65	0.24	0.97	1.13	0.48
Adipocyte differentiation, day08, donor2	13023-139D8	89.40	7.10	4.52	2.90	0.00	0.32	0.65	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	61.32	6.40	1.07	4.27	0.00	0.00	1.07	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	68.44	4.45	3.90	9.46	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	75.69	10.40	4.16	18.30	0.00	1.66	0.83	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	82.13	7.28	4.52	9.04	0.25	0.50	0.50	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	60.54	6.87	2.95	11.45	1.31	0.98	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	59.07	6.70	2.74	24.05	0.30	1.83	0.91	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	93.48	11.27	2.21	2.21	0.00	0.22	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	54.15	7.53	2.15	0.72	0.36	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	35.94	4.79	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	53.07	6.48	1.08	1.44	0.18	0.00	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	35.14	6.69	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	37.60	8.22	1.03	0.82	0.21	0.21	0.21	0.62
Anulus Pulposus Cell, donor1	11248-116E6	32.27	15.91	0.34	1.26	0.23	0.00	0.00	0.46
Anulus Pulposus Cell, donor2	11463-119B5	28.65	11.51	0.73	1.22	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	38.19	11.23	0.90	0.45	0.45	0.00	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	39.94	8.25	0.87	2.17	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	36.38	4.28	2.14	0.00	2.14	0.00	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	41.55	6.88	2.39	0.90	0.60	0.00	0.00	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	30.35	12.65	1.26	3.79	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	23.10	6.60	0.66	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	28.27	4.55	0.32	1.30	0.32	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	31.07	8.74	0.97	0.97	0.97	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	23.76	7.13	0.59	1.19	0.59	0.00	0.00	1.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	31.26	8.66	1.13	1.51	0.75	0.00	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	29.75	7.98	0.00	0.73	0.73	0.00	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	18.81	5.02	1.25	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	38.38	10.71	0.99	1.48	0.00	0.00	0.16	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	24.57	15.01	0.00	2.73	1.36	0.00	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	25.48	7.09	0.45	0.15	0.00	0.00	0.15	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	31.61	8.04	1.07	2.14	0.00	0.00	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	34.20	12.28	1.13	0.94	0.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	24.86	7.22	1.34	0.27	0.53	0.27	0.27	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	30.24	8.78	0.98	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	32.84	8.29	0.50	1.33	0.00	0.17	0.33	0.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	26.42	7.20	2.40	0.00	0.00	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	46.02	3.54	0.00	3.54	0.00	0.00	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	34.82	9.43	1.03	0.69	0.00	0.17	0.17	0.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	41.95	4.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	34.47	8.74	0.49	0.97	0.00	0.00	0.49	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	37.57	8.35	1.14	0.38	0.38	0.00	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	19.38	3.63	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	39.33	5.70	0.00	1.71	0.57	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	32.92	12.61	0.43	0.00	0.21	0.21	0.43	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	24.78	8.26	1.29	1.03	0.00	0.52	0.00	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	35.66	7.98	2.35	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	31.83	9.32	0.32	0.32	0.00	0.00	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	23.54	5.71	1.43	0.00	0.00	0.00	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	30.42	9.94	0.58	1.17	0.00	0.00	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	32.82	10.54	0.30	0.90	0.30	0.30	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	28.51	8.32	1.19	1.19	0.00	0.00	0.00	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	27.97	12.21	0.51	2.03	0.51	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	32.35	11.72	0.25	0.76	1.02	0.00	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	24.14	10.17	1.91	1.27	0.00	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	40.13	9.93	0.86	0.86	0.43	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	30.27	9.31	0.85	1.06	0.21	0.00	0.00	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	22.33	4.64	0.29	0.87	0.00	0.00	0.00	1.45
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	27.40	8.50	0.00	1.89	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	33.40	7.80	0.85	1.02	0.17	0.00	0.17	0.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	32.43	11.58	2.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	50.70	10.56	2.11	4.23	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	35.38	7.93	0.86	0.86	0.43	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	24.67	4.21	2.41	0.60	0.60	0.00	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	29.89	13.12	1.46	0.00	1.46	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	37.24	11.95	1.15	0.92	0.46	0.00	0.00	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	30.60	7.65	2.55	5.10	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	22.63	5.85	1.27	0.76	0.25	0.00	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	40.67	11.56	1.86	0.21	0.41	0.00	0.00	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	24.79	7.65	1.22	0.61	0.00	0.31	0.00	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	40.63	11.95	0.48	1.91	0.00	0.48	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	37.25	8.43	0.67	1.55	0.22	0.22	0.00	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	21.36	9.15	1.53	0.00	1.53	0.00	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	32.68	8.86	1.11	1.11	0.00	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	31.78	6.36	1.59	0.53	0.26	0.00	0.00	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	28.35	5.45	0.36	0.73	0.73	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	62.76	25.55	1.47	2.58	0.00	0.25	0.12	0.00
Astrocyte - cerebellum, donor2	11580-120F5	60.08	18.66	1.37	1.88	0.68	0.17	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	45.52	11.96	1.47	2.10	0.63	0.00	0.00	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	40.44	15.69	0.70	6.97	0.00	1.39	1.05	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	49.34	18.44	1.29	2.91	1.29	0.16	0.97	0.65
Astrocyte - cerebral cortex, donor3	11392-118C6	44.60	13.28	1.19	2.68	0.30	0.30	0.00	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	161.94	0.23	6.42	0.23	1.26	0.00	0.00	1.72
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	177.40	0.38	6.14	0.88	0.88	0.00	0.00	1.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	170.24	0.00	5.23	0.00	0.91	0.00	0.00	1.14
Basophils, donor1	12241-129G9	341.04	0.26	33.48	0.00	0.26	0.26	0.00	0.00
Basophils, donor2	12242-129H1	300.18	0.00	29.95	0.00	1.08	0.36	0.00	0.72
Basophils, donor3	12243-129H2	259.01	0.59	27.93	0.00	0.00	0.00	0.00	0.73
Bronchial Epithelial Cell, donor1	11511-119G8	45.06	5.82	1.72	0.86	0.00	0.22	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	33.37	4.57	0.91	0.46	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	0.00	7.17	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	46.45	6.28	1.26	1.26	0.63	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	42.63	3.74	1.25	0.21	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	26.71	2.99	0.46	0.69	0.23	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	30.95	1.98	0.18	0.36	0.18	0.00	0.00	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	145.20	0.41	15.97	0.21	0.21	0.00	0.00	1.44
Burkitt's lymphoma cell line:RAJI	10476-106I8	151.39	0.00	5.12	0.00	0.47	0.00	0.00	2.10
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	118.96	0.32	6.08	0.32	0.00	0.00	0.32	2.24
CD133+ stem cells - cord blood derived, pool1	12223-129E9	155.13	0.00	10.34	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	284.03	0.00	37.19	0.00	1.69	0.56	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	261.51	0.00	33.59	0.37	1.86	0.00	0.00	0.56
CD14+ Monocytes, donor3	11381-118B4	257.08	0.00	30.30	0.66	1.10	0.00	0.00	2.20
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	431.36	0.00	42.74	0.85	1.13	0.00	0.00	2.83
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	321.08	0.76	47.76	0.76	0.38	0.00	0.00	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	451.03	0.33	62.79	1.31	0.00	0.00	0.00	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	326.68	0.43	38.02	0.14	4.34	0.14	0.14	2.60
CD14+ monocytes - mock treated, donor2	11873-125C1	274.59	0.60	26.25	0.91	0.60	0.00	0.60	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	330.47	0.24	26.53	0.95	0.71	0.00	0.00	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	286.75	0.33	30.30	0.50	1.67	0.17	0.00	2.01
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	240.68	0.83	25.95	1.38	0.55	0.28	0.28	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	291.81	0.50	23.55	0.50	1.49	0.00	0.00	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	216.95	0.20	18.01	0.20	1.17	0.00	0.20	2.15
CD14+ monocytes - treated with BCG, donor2	11870-125B7	199.24	0.18	17.09	0.71	1.42	0.00	0.00	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	267.03	0.00	26.12	0.22	0.87	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	241.15	0.23	25.99	0.23	1.40	0.00	0.23	1.40
CD14+ monocytes - treated with Candida, donor2	11878-125C6	294.11	0.00	26.40	0.00	1.58	0.53	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	274.01	2.22	12.20	1.11	0.00	0.00	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	280.09	0.45	36.00	0.45	1.34	0.00	0.00	3.72
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	258.61	0.40	20.95	0.60	1.60	0.00	0.00	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	350.19	0.21	43.10	1.25	0.83	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	311.15	0.23	40.27	0.23	4.58	0.23	0.23	4.35
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	320.30	0.68	41.85	0.68	1.36	0.23	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	311.20	0.44	34.04	0.00	1.75	0.00	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	257.69	0.00	23.13	1.08	2.96	0.81	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	244.77	0.35	20.41	0.35	1.22	0.52	0.00	1.05
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	295.00	0.00	23.57	0.42	0.84	0.00	0.42	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	320.02	0.18	34.91	0.37	1.29	0.00	0.00	2.76
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	387.49	0.00	34.17	0.35	0.70	0.00	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	373.36	0.00	38.61	0.44	1.32	0.00	0.44	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	176.47	0.52	13.25	0.35	1.22	0.17	0.00	0.87
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	193.27	0.37	17.47	1.49	0.74	0.00	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	249.61	0.43	28.02	0.22	1.29	0.00	0.00	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	271.08	0.00	32.76	0.00	2.87	0.00	0.00	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	330.31	0.00	32.92	0.93	0.23	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	357.73	0.00	39.67	0.70	2.09	0.23	0.23	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	250.44	0.00	16.78	0.44	1.31	0.22	0.00	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	270.49	0.23	18.94	0.00	0.23	0.00	0.00	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	268.17	0.65	21.44	0.22	0.43	0.00	0.22	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	367.35	0.31	28.19	0.62	1.25	0.00	0.00	1.25
CD14+CD16- Monocytes, donor2	11799-124C8	295.32	0.35	20.08	0.70	0.35	0.00	0.00	1.40
CD14+CD16- Monocytes, donor3	11910-125G2	426.32	0.45	33.67	0.67	0.67	0.45	0.00	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	255.43	0.00	19.14	0.00	1.02	0.00	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	266.77	0.66	13.61	0.44	0.44	0.22	0.00	1.10
CD14-CD16+ Monocytes, donor3	11911-125G3	284.45	0.00	18.95	0.21	0.84	0.00	0.00	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	286.56	0.00	10.16	0.00	0.00	0.00	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	301.02	0.68	24.41	0.00	2.71	0.00	0.00	3.39
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	329.32	0.00	25.89	0.00	0.00	0.00	0.00	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	376.32	0.00	29.32	0.53	0.53	0.00	0.00	3.73
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	380.61	0.00	27.88	1.07	0.54	0.00	0.54	2.68
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	280.07	0.00	23.87	0.70	0.70	0.70	0.00	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	305.90	1.57	33.73	0.78	3.14	0.00	0.78	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	329.57	1.32	27.68	1.32	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	256.43	0.82	22.19	0.00	0.00	0.00	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	211.82	0.00	35.55	0.00	0.73	0.00	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	226.67	0.00	27.77	0.50	0.50	0.00	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	88.89	0.40	5.25	0.00	0.00	0.40	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	73.91	0.40	6.39	0.40	0.00	0.00	0.00	0.80
CD34+ Progenitors, donor1	11545-120B6	95.38	2.01	4.02	1.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	129.78	1.12	11.24	0.56	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	118.74	0.75	7.52	0.00	0.38	0.00	0.00	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	123.34	0.00	8.34	0.00	0.00	0.00	0.00	1.13
CD4+ T Cells, donor1	11225-116C1	190.67	0.36	8.57	0.00	0.00	0.00	0.00	0.71
CD4+ T Cells, donor2	11306-117C1	159.21	0.00	12.25	0.61	3.67	0.61	0.00	3.06
CD4+ T Cells, donor3	11382-118B5	154.02	0.30	9.76	0.91	1.22	0.30	0.30	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	114.09	0.00	2.81	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	123.53	0.22	4.27	0.22	0.00	0.00	0.00	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	115.27	0.29	3.45	0.00	0.00	0.00	0.00	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	145.55	0.00	3.79	0.47	0.47	0.47	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	163.64	0.70	2.11	0.70	0.00	0.00	0.00	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	112.07	0.00	0.00	3.30	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	111.42	0.29	3.76	0.00	0.43	0.14	0.00	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	112.69	1.02	3.90	0.17	1.02	0.34	0.00	1.19
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	103.66	0.32	3.39	0.00	0.16	0.00	0.00	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	125.08	0.00	7.17	0.00	0.90	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	141.50	0.35	2.10	0.00	0.35	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	147.83	0.44	2.20	0.00	0.88	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	131.13	0.00	7.59	0.42	0.84	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	118.84	0.42	5.40	0.21	0.21	0.00	0.00	1.45
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	105.58	0.33	2.67	1.00	1.00	0.00	0.00	1.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	175.13	0.00	4.08	0.00	0.54	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	168.82	1.07	3.75	0.00	0.54	0.00	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	202.63	0.00	7.17	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	131.28	1.48	4.08	0.37	0.56	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	112.42	0.87	2.82	0.00	0.65	0.00	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	113.90	0.63	1.89	0.21	0.63	0.00	0.00	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	130.45	1.52	3.54	0.51	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	146.44	1.30	6.93	0.00	0.87	0.00	0.00	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	181.30	0.44	5.23	0.00	1.74	0.00	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	213.29	0.00	4.45	0.00	0.49	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	171.71	0.00	6.46	0.92	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	168.89	1.40	4.19	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	252.01	0.28	7.48	0.28	0.00	0.00	0.00	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	257.91	0.49	10.80	0.49	0.25	0.00	0.00	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	234.08	1.54	9.24	0.00	0.00	0.00	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	220.24	0.36	6.09	0.00	0.00	0.00	0.00	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	177.28	0.00	8.31	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	176.14	0.00	8.18	0.00	0.00	0.00	0.33	0.00
CD8+ T Cells, donor2	11307-117C2	136.66	0.00	9.01	0.38	1.13	0.00	0.00	1.13
CD8+ T Cells, donor3	11383-118B6	150.48	1.01	11.36	0.00	1.51	0.00	0.00	3.28
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	70.88	0.00	2.52	0.00	0.23	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	63.03	0.00	1.92	0.00	0.24	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	62.11	0.00	1.64	0.00	0.27	0.00	0.00	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	51.34	0.00	0.90	0.30	0.30	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	65.28	0.24	1.20	0.00	0.48	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	56.62	0.00	3.18	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	71.05	0.00	1.09	0.00	0.43	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	70.54	0.00	1.84	0.26	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	73.40	0.00	3.28	0.47	0.23	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	79.70	0.00	2.72	0.30	0.30	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	71.17	0.00	2.03	0.00	0.29	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	74.34	0.00	3.20	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	69.16	0.00	3.06	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	79.70	0.00	3.64	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	62.65	0.00	5.22	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	62.31	0.00	2.16	0.00	0.36	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	67.61	0.00	2.30	0.00	0.29	0.00	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	57.98	0.00	2.12	0.00	0.24	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	87.15	0.00	1.27	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	78.12	0.00	1.23	0.31	0.00	0.00	0.00	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	67.00	0.32	2.89	0.00	0.32	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	69.23	0.00	3.06	0.38	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	72.91	0.00	0.39	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	63.54	0.00	1.51	0.00	0.00	0.00	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	73.07	0.00	4.01	0.80	0.00	0.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	78.34	0.00	4.90	2.10	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	90.16	0.00	2.00	0.00	1.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	34.73	7.31	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	32.12	3.95	2.96	0.99	0.49	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	52.20	6.21	1.26	0.21	0.00	0.21	0.11	0.21
Chondrocyte - de diff, donor1	11261-116G1	38.13	6.24	0.00	1.39	0.35	0.00	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	33.76	7.11	0.71	0.00	0.00	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	32.31	6.94	0.57	0.68	0.23	0.00	0.23	0.46
Chondrocyte - re diff, donor2	11339-117F7	47.45	8.95	0.90	2.69	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	38.42	4.45	0.40	0.40	0.81	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	47.40	15.84	0.92	1.61	0.23	0.11	0.11	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	39.33	10.26	0.00	1.07	0.21	0.21	0.00	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	34.25	8.41	0.44	0.97	0.18	0.27	0.09	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	101.97	11.10	3.85	1.65	0.28	0.18	0.37	0.18
Corneal Epithelial Cells, donor1	11526-119I5	53.14	4.61	0.44	1.10	0.00	0.44	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	31.85	5.69	2.28	1.14	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	47.80	4.60	2.05	0.26	0.00	0.26	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	210.17	0.50	9.25	0.00	0.66	0.17	0.00	0.83
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	218.89	0.00	11.04	0.63	0.63	0.00	0.00	0.95
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	169.08	0.00	10.35	0.00	3.45	0.00	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	179.15	0.00	8.96	0.43	0.97	0.11	0.32	1.19
Dendritic Cells - plasmacytoid, donor1	11228-116C4	276.73	0.34	16.06	0.00	2.05	0.00	0.00	1.37
Dendritic Cells - plasmacytoid, donor2	11309-117C4	327.74	0.00	22.20	0.00	0.00	0.00	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	310.69	0.00	28.55	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	56.53	4.17	2.33	0.67	0.00	0.00	0.17	0.67
Endothelial Cells - Aortic, donor1	11263-116G3	55.16	4.11	2.35	1.76	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	84.27	8.48	1.70	0.57	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	58.19	7.86	2.36	0.79	0.00	0.00	0.39	0.39
Endothelial Cells - Artery, donor1	11264-116G4	42.47	7.27	3.20	1.16	0.00	0.58	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	55.76	4.47	1.65	1.65	0.00	0.00	0.24	0.24
Endothelial Cells - Artery, donor3	11413-118E9	54.00	4.91	1.05	1.05	0.35	0.53	0.00	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	48.99	3.77	1.33	0.22	0.00	0.00	0.00	0.89
Endothelial Cells - Lymphatic, donor2	11317-117D3	53.55	7.61	1.83	1.22	0.91	0.30	0.30	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	45.95	6.48	2.54	0.85	0.28	0.00	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	46.65	14.26	1.49	2.38	0.30	0.30	0.59	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	51.55	8.33	3.12	0.52	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	35.87	10.49	0.57	0.14	0.14	0.14	0.00	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	83.63	6.40	3.20	2.80	0.00	0.00	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	44.55	10.48	1.05	1.57	0.52	0.52	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	86.23	6.59	3.11	0.75	0.25	0.12	0.12	0.99
Endothelial Cells - Umbilical vein, donor2	11324-117E1	66.70	4.78	1.74	0.65	0.22	0.22	0.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	74.01	4.89	4.03	0.61	0.49	0.12	0.12	0.24
Endothelial Cells - Vein, donor1	11267-116G7	48.91	4.55	1.14	2.28	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	60.07	2.10	2.10	0.00	0.00	0.00	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	57.31	6.91	1.26	1.73	0.16	0.00	0.16	0.94
Eosinophils, donor1	12244-129H3	320.19	0.00	60.99	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1353.22	0.00	103.97	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	1059.35	0.00	103.44	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	45.20	6.11	1.22	1.47	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	39.52	2.08	4.16	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	43.10	5.75	1.64	1.64	0.41	0.00	0.41	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	20.69	6.46	0.55	0.99	0.22	0.22	0.44	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	27.41	4.12	0.87	0.98	0.43	0.11	0.00	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	56.40	8.97	1.94	2.18	0.36	0.12	0.00	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	47.90	11.19	1.23	1.77	0.41	0.00	0.00	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	36.60	7.59	0.95	0.32	0.32	0.11	0.11	0.95
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	33.99	8.43	0.79	0.53	0.00	0.00	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	51.16	7.64	0.66	0.66	0.00	0.00	0.00	1.00
Fibroblast - Cardiac, donor1	11268-116G8	40.83	6.35	0.91	0.91	0.91	0.45	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	42.45	3.03	1.52	0.76	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	36.27	6.47	1.10	1.26	0.00	0.00	0.00	0.16
Fibroblast - Cardiac, donor4	11452-119A3	40.62	7.27	0.91	1.21	0.30	0.00	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	40.48	4.44	0.51	0.63	0.38	0.13	0.00	0.00
Fibroblast - Cardiac, donor6	11460-119B2	41.08	5.91	0.61	0.45	0.30	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	59.49	12.33	1.61	1.74	0.13	0.13	0.00	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	38.83	3.02	0.86	0.00	0.43	0.00	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	39.55	7.32	1.46	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	67.35	11.30	0.69	1.38	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	38.50	5.60	0.51	0.34	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	41.09	7.75	0.23	0.94	0.00	0.23	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	57.54	6.60	0.47	1.42	0.00	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	42.19	5.56	0.85	0.73	0.24	0.12	0.00	0.97
Fibroblast - Dermal, donor4	11450-119A1	37.76	6.22	0.68	1.02	0.23	0.23	0.00	0.00
Fibroblast - Dermal, donor5	11454-119A5	45.36	6.45	0.52	0.70	0.17	0.17	0.00	0.35
Fibroblast - Dermal, donor6	11458-119A9	49.05	8.28	1.30	0.65	0.65	0.00	0.00	0.16
Fibroblast - Gingival, donor1	11237-116D4	45.60	9.37	0.21	1.04	0.21	0.00	0.00	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	52.66	10.22	1.57	0.79	0.26	0.26	0.00	0.26
Fibroblast - Gingival, donor2	11318-117D4	49.95	10.15	0.79	0.66	0.66	0.00	0.26	0.79
Fibroblast - Gingival, donor3	11394-118C8	38.00	4.54	0.39	0.58	0.39	0.19	0.10	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	50.91	9.35	0.00	0.00	1.04	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	36.47	4.93	0.35	1.41	0.18	0.18	0.35	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	55.03	10.29	0.94	0.78	0.00	0.31	0.00	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	45.44	10.95	0.95	2.43	0.95	0.41	0.14	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	31.41	6.70	0.71	0.71	0.00	0.35	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	41.24	12.87	0.88	1.90	0.15	0.15	0.00	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	47.04	9.14	1.36	0.95	0.41	0.00	0.00	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	57.70	7.24	0.88	1.54	0.11	0.22	0.11	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	30.52	6.90	0.59	0.44	0.29	0.00	0.00	0.00
Fibroblast - Lung, donor1	11270-116H1	13.59	4.08	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	41.78	11.94	0.00	1.49	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	42.63	6.75	0.21	0.42	0.63	0.21	0.00	1.06
Fibroblast - Lymphatic, donor1	11506-119G3	98.30	14.16	1.67	0.83	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	23.78	8.39	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	37.78	3.64	0.84	1.12	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	95.81	12.59	0.81	2.44	0.41	0.41	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	95.86	11.98	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	29.78	5.96	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	51.40	9.31	1.55	0.58	0.00	0.58	0.00	0.97
Fibroblast - Periodontal Ligament, donor2	11319-117D5	52.18	6.98	0.61	1.06	1.06	0.00	0.15	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	61.20	10.71	0.92	0.92	0.00	0.61	0.92	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	46.56	13.74	1.14	0.76	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	44.01	11.07	0.81	2.16	0.27	0.27	0.27	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	44.07	4.99	1.16	0.58	0.35	0.12	0.00	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	66.87	8.40	3.09	0.88	0.22	0.11	0.00	1.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	104.03	10.77	2.03	1.02	0.20	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	60.14	6.68	0.67	0.67	0.00	0.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	33.21	5.54	0.00	0.00	0.00	0.00	0.00	1.58
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	50.01	10.91	1.19	0.60	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	36.94	4.09	0.71	1.24	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	42.57	7.69	0.79	0.99	0.00	0.00	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	37.31	5.42	0.60	0.00	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	53.11	11.12	0.86	1.08	0.11	0.11	0.00	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	42.77	7.59	0.76	0.51	0.00	0.00	0.00	0.25
Fibroblast - skin normal, donor1	11553-120C5	43.81	5.41	1.48	0.49	0.33	0.00	0.33	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	53.74	13.23	1.00	0.80	0.00	0.00	0.00	0.40
Fibroblast - skin normal, donor2	11561-120D4	51.34	13.96	1.31	1.31	0.30	0.40	0.20	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	49.87	11.18	0.30	1.21	0.30	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	37.36	5.63	0.83	0.50	0.25	0.00	0.08	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	47.01	6.67	0.68	0.68	0.34	0.17	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	43.35	11.50	0.00	0.99	0.33	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	58.59	16.62	1.28	2.02	0.11	0.21	0.21	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	56.51	11.13	2.36	1.35	0.17	0.17	0.00	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	32.62	9.10	0.78	1.41	0.47	0.00	0.00	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	221.60	22.16	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	50.55	4.36	0.87	0.87	0.87	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	55.82	7.11	1.21	2.25	0.00	0.17	0.00	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	49.19	8.33	1.30	0.26	0.00	0.00	0.52	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	63.62	8.18	2.81	0.51	0.00	0.26	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	55.12	5.36	0.00	8.42	0.00	0.77	0.77	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	54.87	12.12	5.10	12.12	0.64	0.64	1.91	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	60.19	16.83	3.71	13.12	0.86	0.29	0.57	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	46.88	11.58	0.55	13.79	0.55	3.03	1.10	3.31
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	29.45	13.01	1.14	9.36	0.23	1.83	0.46	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	55.48	11.29	1.59	6.54	1.19	1.39	0.59	1.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	39.91	8.99	0.79	14.01	0.00	2.11	0.53	2.11
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	27.40	16.63	0.98	7.83	0.65	1.30	0.65	1.96
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	63.68	15.92	1.77	11.94	0.00	1.33	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	59.92	9.75	1.13	5.37	0.28	0.71	0.42	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	55.29	9.85	1.11	4.80	0.25	0.25	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	58.02	7.79	1.88	5.10	1.34	0.54	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	61.82	5.82	1.98	1.36	0.37	0.25	0.37	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	62.85	5.81	1.11	3.18	0.28	0.14	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	51.84	7.52	2.85	2.44	0.20	0.61	0.41	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	49.74	7.07	1.14	2.51	0.00	0.46	0.23	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	58.80	6.48	1.49	3.74	0.37	0.25	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	69.29	6.12	2.40	1.53	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	51.41	7.09	1.77	2.36	0.59	0.30	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	52.93	6.99	1.11	1.59	0.32	0.00	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	55.63	3.80	2.46	2.01	0.00	0.45	0.22	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	40.53	9.48	1.21	2.02	0.20	0.20	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	55.98	8.65	0.85	4.07	0.17	0.00	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	79.01	8.69	3.19	2.31	0.09	0.18	0.27	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	55.98	8.53	1.35	2.71	0.21	0.21	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	42.35	6.83	0.85	3.07	0.00	0.51	0.34	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	46.36	7.86	1.33	2.21	0.00	0.66	0.33	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	65.14	6.66	3.33	2.00	0.08	0.42	0.42	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	63.30	7.15	1.63	2.25	0.20	0.00	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	40.85	8.05	0.83	1.24	0.00	0.62	0.21	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	40.81	6.57	0.92	1.84	0.12	0.23	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	46.86	4.50	0.83	2.17	0.17	0.00	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	32.62	7.49	1.76	1.76	0.00	0.22	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	44.77	5.41	0.98	2.46	0.25	0.25	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	49.11	7.29	1.30	1.78	0.00	0.00	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	35.92	7.38	2.25	0.96	0.32	0.64	0.32	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	44.72	7.20	0.85	2.27	0.19	0.19	0.19	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	43.18	6.33	1.42	0.63	0.47	0.00	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	50.48	6.99	1.82	3.34	1.22	0.61	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	48.09	7.74	1.46	1.88	0.31	0.21	0.21	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	36.45	3.07	1.54	0.88	0.22	0.22	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	44.89	10.94	0.84	0.84	1.12	0.00	0.84	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	46.20	7.41	0.46	1.94	0.19	0.09	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	42.78	7.75	1.07	1.60	0.00	0.00	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	57.53	8.26	1.68	1.84	0.15	0.46	0.00	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	48.19	6.99	0.91	1.42	0.39	0.13	0.00	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	39.03	6.51	0.81	0.54	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	41.11	11.06	0.92	1.29	0.37	0.55	0.18	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	42.33	11.18	1.10	0.88	0.00	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	40.66	6.94	0.00	0.99	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	42.87	9.10	0.66	0.53	0.00	0.26	0.26	0.92
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	38.33	10.29	1.21	1.01	0.20	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	48.54	10.93	1.52	1.02	0.00	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	89.78	16.52	3.18	14.13	0.00	1.00	0.80	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	61.17	9.40	1.23	3.08	0.15	0.46	0.31	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	72.22	17.18	2.05	12.68	0.20	1.23	1.43	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	65.72	8.76	2.50	7.51	0.31	1.88	0.31	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	49.73	7.63	1.41	6.22	0.28	1.70	0.85	1.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	71.95	6.92	1.38	6.92	0.00	0.92	0.00	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	71.77	14.85	0.00	19.80	0.00	2.47	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	65.37	12.38	1.55	7.74	1.55	0.77	1.55	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	64.18	12.84	3.21	6.42	3.21	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	53.90	13.91	0.00	3.48	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	59.89	10.09	0.98	3.58	0.98	0.33	0.65	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	66.71	10.71	0.00	4.53	0.00	0.82	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	66.65	6.66	0.00	3.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	57.33	5.59	2.52	2.80	0.28	0.28	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	58.50	6.86	0.98	4.90	0.65	0.98	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	54.52	5.87	0.84	2.52	0.00	0.84	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	61.07	6.68	2.23	2.54	0.00	0.00	0.32	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	57.40	5.09	1.70	2.72	0.34	0.00	1.36	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	54.29	6.26	0.00	2.09	2.09	0.00	2.09	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	68.72	4.01	1.15	2.86	0.57	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	55.05	5.33	0.89	2.66	0.89	0.30	0.00	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	57.60	6.78	0.00	1.69	0.00	0.00	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	54.26	9.94	1.24	3.31	1.24	0.83	0.83	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	49.71	7.13	1.84	3.22	0.69	0.46	0.92	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	47.42	5.27	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	50.74	6.92	1.92	2.69	0.77	0.00	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	44.98	4.89	2.28	2.61	0.00	0.00	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	35.45	3.34	0.67	5.35	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	52.78	6.55	0.77	1.16	0.39	0.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	64.36	7.53	1.71	3.08	0.34	0.00	0.34	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	47.21	2.48	2.48	2.48	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	51.90	6.13	0.94	2.36	0.47	0.00	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	49.49	5.43	1.21	1.21	0.00	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	41.71	5.60	0.00	5.60	1.02	1.02	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	43.87	3.59	1.20	1.20	0.40	0.00	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	46.87	7.89	0.99	2.47	0.49	0.49	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	50.76	4.72	1.18	3.54	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	46.68	7.00	1.75	1.75	0.58	1.17	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	56.62	2.63	0.44	1.76	0.44	0.44	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	60.19	6.78	1.70	2.54	1.70	0.85	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	42.98	10.74	0.60	4.78	0.00	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	33.97	7.76	0.49	1.94	0.00	0.00	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	34.24	2.28	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	32.02	5.41	1.25	0.42	0.42	0.00	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	41.60	10.12	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	26.01	7.61	0.95	0.63	0.32	0.32	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	25.48	5.85	1.25	0.42	0.00	0.00	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	71.95	3.25	2.44	2.09	0.93	0.23	0.12	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	67.52	3.54	3.54	2.03	0.51	0.00	0.17	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	70.07	2.28	1.59	1.37	0.23	0.00	0.23	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	77.06	3.17	4.48	1.42	0.77	0.11	0.00	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	73.71	3.65	3.01	0.86	0.64	0.43	0.00	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	69.97	2.58	2.37	0.86	0.22	0.22	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	66.13	2.74	3.24	2.24	0.37	0.00	0.12	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	66.39	3.26	2.23	1.54	0.00	0.17	0.17	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	56.71	3.20	0.96	1.28	0.32	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	69.39	6.72	3.36	2.80	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	68.38	6.49	3.46	0.87	0.00	0.00	0.43	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	42.30	7.93	0.00	2.64	5.29	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	69.49	14.11	0.35	0.71	0.00	0.35	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	50.86	15.98	2.91	2.91	0.00	0.00	0.73	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	43.71	3.67	1.22	0.35	0.17	0.00	0.00	0.35
Hepatocyte, donor1	11523-119I2	70.21	2.42	3.63	1.21	1.21	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	100.19	1.08	1.08	0.00	0.00	0.00	0.00	2.15
Hepatocyte, donor3	11684-122I1	71.78	4.29	1.84	1.23	1.23	0.00	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	81.59	6.53	10.44	1.96	0.65	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	106.44	3.85	4.72	0.52	0.35	0.00	0.00	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	41.02	8.64	0.69	0.69	0.00	0.14	0.00	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	76.41	0.00	3.18	0.00	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	63.68	0.00	1.38	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	35.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	130.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	30.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	41.14	0.00	9.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	71.47	1.62	1.62	1.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	43.35	0.00	0.00	0.00	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	72.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	63.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	67.63	0.00	2.22	1.11	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	78.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	59.84	0.00	0.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	66.50	0.00	0.00	0.00	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	48.45	0.00	2.58	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	45.08	0.00	1.61	0.00	0.00	0.00	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	131.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	65.19	0.00	1.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	66.75	0.00	3.36	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	61.08	0.80	0.00	0.00	0.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	51.70	0.92	2.77	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	69.86	0.47	0.47	0.00	0.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	48.07	0.91	3.63	0.00	0.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	53.81	1.08	1.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	66.06	0.00	1.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	51.01	0.00	2.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	54.68	0.00	1.82	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	47.84	1.43	0.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	33.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	63.89	0.31	1.54	0.31	0.62	0.00	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	47.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	53.43	0.00	6.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	52.15	1.39	0.70	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	61.97	2.21	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	58.36	0.00	3.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	42.72	0.87	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	51.75	0.00	2.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	31.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	55.47	0.00	1.07	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	48.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	45.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	57.99	0.92	0.00	0.00	0.92	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	51.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	62.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	42.29	0.00	1.06	1.06	1.06	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	40.55	8.24	1.39	2.45	0.24	0.49	0.00	0.49
Keratinocyte - epidermal, donor2	11349-117G8	17.57	1.17	0.59	0.59	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	53.76	3.60	1.23	0.19	0.38	0.09	0.00	0.57
Keratinocyte - oral, donor1	11251-116E9	56.30	8.74	0.57	0.45	0.34	0.11	0.00	0.11
Keratocytes, donor1	11527-119I6	104.18	7.22	1.38	0.34	0.69	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	56.25	7.03	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	49.99	0.79	0.40	0.20	0.40	0.00	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	101.10	2.20	2.20	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	34.52	8.63	1.08	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	52.94	17.07	1.04	1.38	0.00	0.23	0.00	0.58
Lens Epithelial Cells, donor3	11690-122I7	53.38	12.21	1.51	1.31	0.00	0.00	0.10	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	46.25	9.13	1.66	1.66	0.24	0.12	0.12	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	27.91	3.63	3.07	0.84	0.00	0.00	0.28	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	44.55	5.35	1.89	0.94	0.63	0.00	0.00	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	30.11	5.91	1.08	0.00	0.00	0.00	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	38.77	6.93	1.89	0.00	0.00	0.00	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	38.81	8.52	0.86	0.97	0.22	0.22	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	35.29	4.51	0.41	2.05	0.41	0.00	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	27.56	6.07	4.30	0.76	0.25	0.00	0.00	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	36.88	7.32	1.27	1.13	0.28	0.14	0.14	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	22.15	5.14	0.79	1.98	0.00	0.00	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	26.56	3.88	1.16	1.94	0.00	0.00	0.00	1.55
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	32.03	7.22	1.30	0.93	0.19	0.00	0.00	0.93
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	36.93	4.88	2.09	0.70	0.35	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	27.19	5.01	2.62	1.91	0.00	0.24	0.00	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	41.07	7.55	1.79	1.65	0.00	0.27	0.14	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	31.41	6.16	0.62	1.54	0.31	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	26.50	2.81	0.94	0.62	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	44.65	6.77	1.83	1.83	0.37	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	26.66	6.58	1.32	1.97	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	28.70	4.10	2.05	0.59	0.29	0.29	0.00	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	40.58	7.47	1.00	1.49	0.25	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	38.80	3.39	1.45	0.48	0.00	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	22.35	4.31	1.62	0.27	0.00	0.00	0.00	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	43.14	7.57	2.42	1.67	0.00	0.00	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	29.55	3.63	1.04	2.07	0.52	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	22.61	5.03	1.88	0.63	0.00	0.00	0.42	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	40.00	6.62	1.20	1.80	0.60	0.15	0.30	0.60
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	39.21	6.88	0.00	2.75	1.38	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	22.95	4.14	0.94	1.13	0.00	0.00	0.00	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	38.28	7.10	1.59	1.59	0.11	0.00	0.21	0.64
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	37.31	3.88	2.42	0.48	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	23.16	5.29	3.31	2.32	0.00	0.00	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	39.65	5.33	1.86	1.61	0.25	0.12	0.12	1.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	43.68	4.81	1.85	0.74	1.11	0.37	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	22.24	4.69	1.24	0.49	0.00	0.25	0.00	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	32.04	5.22	1.37	1.65	0.00	0.00	0.00	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	35.70	5.47	1.29	0.32	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	27.39	4.56	3.65	0.61	0.30	0.00	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	37.93	6.30	1.68	1.68	0.28	0.00	0.00	0.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	37.33	3.91	1.42	0.71	0.71	0.00	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	19.88	2.91	0.97	1.45	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	39.99	5.45	0.93	1.24	0.16	0.31	0.31	0.93
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	42.97	4.66	0.72	0.36	0.36	0.36	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	33.97	6.21	2.61	2.61	0.65	0.65	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	29.66	6.12	1.41	1.41	0.24	0.00	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	61.50	9.28	1.49	1.49	0.37	0.37	0.12	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	24.84	4.87	0.77	2.05	0.26	0.00	0.00	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	41.17	7.76	0.90	1.49	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	154.09	15.86	2.27	0.00	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	131.95	7.67	2.30	1.53	0.00	0.00	0.00	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	129.89	8.16	3.71	1.48	0.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	126.94	5.08	2.96	1.69	1.69	0.00	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	113.24	6.33	2.11	0.70	0.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	106.47	3.74	3.74	0.00	0.00	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	94.29	6.70	5.15	2.06	3.09	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	117.76	3.57	1.19	1.19	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	132.32	6.56	3.62	0.68	0.00	0.00	0.00	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	137.56	5.82	2.62	1.45	1.45	0.00	0.00	1.74
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	162.51	7.20	4.05	2.25	2.25	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	163.26	8.81	3.52	1.08	0.41	0.14	0.14	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	117.08	5.65	3.08	1.54	1.03	0.00	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	165.49	10.59	5.65	0.71	1.41	0.00	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	142.59	6.00	0.67	0.67	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	117.67	8.15	3.57	1.02	3.06	0.51	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	179.29	11.47	3.20	1.07	1.07	0.00	0.27	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	167.03	10.20	5.67	1.70	1.89	0.19	0.00	1.32
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	123.33	6.75	3.07	0.00	1.84	0.00	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	170.42	5.71	6.52	0.82	1.63	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	163.26	6.87	5.00	2.50	1.67	0.00	0.21	1.67
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	149.66	7.29	5.04	3.08	1.40	0.00	0.00	1.96
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	130.85	5.15	6.18	2.06	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	168.67	6.39	4.35	1.16	3.48	0.29	0.00	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	141.09	7.77	3.29	1.49	1.79	0.00	0.30	1.49
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	162.10	4.98	5.53	1.66	1.66	0.00	0.00	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	145.64	6.01	3.18	1.06	2.47	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	120.96	5.90	4.06	1.48	1.48	0.37	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	111.67	1.15	2.30	1.15	1.15	0.00	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	145.06	7.29	2.30	2.69	0.77	0.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	133.04	3.96	6.23	1.13	3.96	0.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	122.25	4.92	4.10	2.46	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	129.24	2.26	4.07	1.81	1.81	0.00	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	132.86	7.90	3.59	0.72	2.15	0.00	1.44	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	152.37	5.98	5.98	2.24	0.00	0.00	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	137.49	9.66	2.97	1.49	1.49	0.00	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	139.99	7.75	3.02	1.29	2.15	0.00	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	134.44	3.43	2.57	1.71	0.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	144.60	8.33	2.67	2.00	2.67	0.00	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	134.54	6.03	7.24	3.62	1.21	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	125.85	4.98	2.84	0.71	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	131.64	5.50	2.06	2.41	1.37	0.00	0.00	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	136.87	2.68	4.29	0.54	1.07	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	136.69	2.69	2.02	1.35	0.67	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	126.68	8.89	1.85	0.37	1.48	0.00	0.00	2.59
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	181.42	1.16	4.65	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	129.04	2.12	2.12	1.06	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	130.05	7.20	2.40	2.00	3.20	0.00	0.00	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	117.75	3.63	2.91	2.18	0.73	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	142.57	10.73	6.90	3.07	0.00	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	131.71	7.40	4.93	0.49	4.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	113.85	5.65	4.70	3.76	2.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	145.32	10.06	2.51	0.50	1.01	0.00	0.00	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	122.57	4.96	4.96	1.80	1.35	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	117.04	1.72	1.72	10.33	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	139.39	8.91	5.34	2.23	0.89	0.00	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	136.08	13.69	5.08	3.52	1.17	0.00	0.78	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	131.95	9.24	3.30	1.98	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	158.79	6.75	1.56	1.56	1.04	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	181.15	6.56	3.94	1.31	0.00	0.00	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	145.93	5.59	5.59	1.12	2.24	0.56	0.56	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	153.25	10.60	4.86	1.77	1.32	0.00	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	145.03	7.33	5.40	2.31	1.93	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	144.82	7.60	4.56	1.01	3.04	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	166.78	6.73	4.33	1.44	0.96	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	151.86	10.34	2.39	1.19	1.99	0.00	0.00	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	125.17	2.43	6.08	2.43	0.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	135.57	9.68	3.46	1.38	1.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	140.60	6.46	3.42	2.28	3.04	0.00	0.00	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	120.33	5.16	5.68	2.58	1.55	0.00	0.00	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	135.44	6.05	2.42	2.42	0.60	0.00	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	149.58	5.39	5.70	1.27	3.80	0.00	0.00	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	139.67	5.86	5.86	4.26	3.20	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	134.47	5.17	3.45	0.00	0.57	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	154.27	7.20	6.17	1.03	3.60	0.51	0.00	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	160.57	12.73	2.83	0.71	0.71	0.00	0.00	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	136.76	5.11	0.57	0.00	1.13	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	141.86	7.90	3.33	2.08	2.50	0.42	0.00	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	151.13	5.48	4.70	2.35	2.35	0.00	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	132.36	5.43	4.59	0.00	0.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	148.22	9.29	2.79	4.65	2.79	0.00	0.00	1.86
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	144.51	8.03	3.35	3.35	1.34	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	159.32	3.74	3.74	1.07	1.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	178.61	8.89	5.25	1.62	2.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	135.83	7.34	5.51	1.84	1.84	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	160.93	3.56	7.11	1.78	0.89	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	170.39	5.13	6.27	1.14	1.14	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	167.95	3.07	4.60	2.30	3.07	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	159.78	3.28	2.19	1.64	1.09	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	164.37	4.90	5.79	1.34	0.00	0.00	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	185.87	4.16	3.64	0.78	0.78	0.00	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	161.80	2.65	4.64	1.99	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	166.29	6.24	2.08	0.00	2.08	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	381.07	0.91	51.74	4.10	1.14	0.00	0.00	2.51
Macrophage - monocyte derived, donor2	11313-117C8	254.52	3.12	18.17	3.85	0.00	0.00	0.18	0.37
Macrophage - monocyte derived, donor3	11389-118C3	321.41	1.97	36.18	3.80	1.84	0.26	0.00	1.44
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	44.61	12.21	1.59	0.53	0.00	0.00	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	39.61	9.19	0.63	2.22	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	48.92	12.37	1.53	1.25	0.28	0.28	0.00	0.42
Mammary Epithelial Cell, donor1	11273-116H4	46.63	5.38	0.80	1.00	0.30	0.10	0.10	0.70
Mammary Epithelial Cell, donor2	11350-117G9	50.09	6.08	0.00	0.87	0.29	0.29	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	26.94	3.49	0.00	0.50	0.00	0.25	0.00	0.75
Mast cell - stimulated, donor1	11487-119E2	129.49	2.71	3.39	0.00	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	191.08	3.68	10.38	0.22	0.43	0.00	0.00	0.65
Mast cell, donor2	11565-120D8	206.24	4.46	7.13	0.89	0.00	0.00	0.00	0.00
Mast cell, donor3	11566-120D9	202.84	3.38	8.10	0.00	0.90	0.00	0.00	2.93
Mast cell, donor4	11567-120E1	212.75	3.90	7.45	1.42	0.00	0.00	0.18	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	154.58	2.00	4.44	0.11	0.44	0.11	0.00	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	134.25	0.00	11.09	0.00	0.58	0.00	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	187.00	1.72	5.97	0.23	1.03	0.00	0.00	1.03
Mast cell, expanded, donor8	11941-126A6	193.98	2.51	17.74	1.51	0.33	0.00	0.17	1.00
Melanocyte - dark, donor1	11502-119F8	58.01	6.07	1.69	0.70	0.10	0.20	0.20	0.00
Melanocyte - dark, donor2	11582-120F7	35.65	3.81	0.00	0.00	0.00	0.35	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	75.63	6.88	2.10	0.22	0.14	0.07	0.00	0.36
Melanocyte - light, donor1	11274-116H5	41.61	2.82	0.71	0.24	0.00	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	47.09	3.41	0.68	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	36.42	4.34	0.87	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	63.20	2.60	1.04	0.21	0.10	0.00	0.00	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	59.97	2.42	1.88	0.54	0.27	0.00	0.00	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	49.29	6.16	0.27	0.00	0.27	0.00	0.00	0.00
Meningeal Cells, donor1	11493-119E8	82.38	11.54	2.36	1.12	0.00	0.00	0.12	0.00
Meningeal Cells, donor2	11573-120E7	62.06	11.00	1.32	0.88	0.00	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	59.99	6.19	1.71	0.98	0.24	0.24	0.16	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	53.89	16.82	0.00	1.71	0.57	0.29	0.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	44.08	3.22	0.91	0.60	0.20	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	23.65	2.63	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	37.94	5.23	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	62.43	2.87	0.00	0.00	0.00	0.00	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	37.91	9.53	0.85	2.12	0.21	0.21	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	33.68	7.54	1.51	1.01	0.00	0.50	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	77.79	13.84	1.10	1.32	0.00	0.44	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	59.91	10.96	1.46	3.65	0.00	0.00	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	54.22	11.25	2.46	1.64	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	32.96	9.83	0.55	0.28	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	51.67	4.09	0.37	0.37	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	43.55	3.68	1.58	0.53	0.39	0.13	0.00	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	36.20	4.45	0.89	0.30	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	28.03	0.00	2.34	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	51.23	1.92	0.00	0.64	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	74.79	4.25	1.06	1.06	0.35	0.00	0.00	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	48.47	3.75	0.94	0.94	0.31	0.00	0.00	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	42.09	3.63	0.73	0.73	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	52.77	12.73	2.12	1.59	0.53	0.27	0.27	0.27
Mesothelial Cells, donor2	12156-128G5	52.55	12.01	1.50	2.00	0.00	0.50	0.50	0.50
Mesothelial Cells, donor3	11402-118D7	38.37	10.55	0.51	1.37	0.29	0.07	0.07	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	496.92	0.00	22.96	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	264.50	0.25	14.53	0.49	0.74	0.00	0.00	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	221.43	0.59	13.25	0.59	0.88	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	643.02	0.00	34.57	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	200.23	0.00	15.81	0.31	0.00	0.00	0.00	1.55
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	171.34	0.21	9.13	0.41	0.41	0.21	0.00	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	528.06	0.00	27.79	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	225.74	0.25	16.02	0.50	0.50	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	244.84	0.47	14.90	0.47	0.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	739.71	0.00	58.40	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	216.02	0.20	17.27	0.81	0.81	0.00	0.00	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	205.50	0.00	14.65	0.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	761.08	0.00	34.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	188.49	0.00	11.50	0.00	0.88	0.00	0.00	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	178.19	0.38	15.58	0.00	0.38	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	459.25	0.00	44.74	0.00	0.00	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	192.28	0.64	13.58	0.42	0.85	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	204.42	0.00	21.18	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	195.52	0.00	11.03	0.60	0.30	0.00	0.60	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	308.51	1.68	20.12	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	1154.28	0.00	67.90	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	174.63	0.00	15.81	0.00	2.26	0.00	0.00	1.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	170.41	0.24	11.17	0.00	0.00	0.00	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	393.65	0.00	22.12	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	168.54	0.00	12.66	0.23	1.15	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	176.47	0.00	13.04	0.84	0.84	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	188.13	0.00	14.06	0.00	0.41	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	158.33	0.00	10.30	0.64	0.21	0.00	0.21	1.72
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	179.83	0.22	13.34	0.44	0.00	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	681.02	0.00	61.91	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	171.27	0.22	9.42	0.00	0.22	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	187.57	0.00	9.63	0.00	0.00	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	483.84	1.66	53.02	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	185.36	0.54	12.50	0.82	0.00	0.00	0.00	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	194.68	0.88	19.12	0.59	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	463.39	0.00	34.89	2.18	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	166.27	0.48	9.61	0.48	0.48	0.00	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	200.91	0.00	18.81	1.20	0.80	0.00	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	507.35	1.37	41.14	0.00	0.00	0.00	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	199.73	0.00	15.02	1.00	0.00	0.00	0.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	269.47	0.00	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	371.01	2.04	18.35	0.00	0.00	0.00	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	232.54	0.88	21.02	0.00	0.44	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	462.43	0.00	28.69	3.31	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	532.80	0.00	43.55	1.28	0.00	0.00	0.64	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	276.18	0.50	23.06	0.50	1.24	0.00	0.00	0.99
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	375.78	1.39	29.92	1.39	0.00	0.00	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	994.44	2.21	46.41	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	341.19	0.68	30.09	0.68	0.68	0.00	0.00	3.42
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	378.97	1.31	29.32	1.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	471.57	0.71	35.86	0.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	306.08	0.56	27.21	1.40	1.40	0.28	0.28	1.96
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	338.32	0.42	27.43	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	539.04	1.75	39.63	0.58	0.00	0.00	0.58	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	305.89	0.90	26.24	0.60	0.90	0.30	0.00	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	267.13	2.50	24.63	2.09	0.42	0.42	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	866.26	0.00	93.84	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	331.56	0.92	24.94	0.00	4.62	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	383.02	2.28	26.75	1.71	0.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	347.53	0.55	20.45	2.07	0.41	0.00	0.28	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	289.99	0.26	29.02	1.30	1.04	0.26	0.26	2.59
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	341.89	1.29	29.17	2.57	0.00	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	564.69	0.64	38.75	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	313.86	2.94	24.02	0.80	0.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	392.72	2.39	31.13	2.99	0.60	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	287.03	0.57	17.52	0.42	0.28	0.00	0.28	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	286.34	0.96	23.25	1.59	1.59	0.00	0.00	3.82
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	352.26	3.98	29.41	2.87	0.44	0.22	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	458.07	0.00	32.99	0.38	0.38	0.00	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	307.40	0.28	23.30	2.56	0.85	0.00	0.28	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	316.35	3.44	22.86	2.70	1.23	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	514.17	1.30	33.24	0.00	0.00	0.00	0.65	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	327.55	1.18	25.29	1.18	1.76	0.29	0.00	1.18
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	373.09	3.17	29.70	6.63	0.58	0.58	0.29	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	421.21	1.65	45.75	1.24	1.24	0.41	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	384.44	2.08	27.40	3.87	0.60	0.00	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	233.55	0.00	18.83	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	221.00	1.78	17.82	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	276.99	0.33	23.66	0.00	0.00	0.00	0.00	2.63
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	210.39	0.00	19.99	1.05	0.00	0.00	1.05	5.26
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	222.60	0.99	14.63	0.20	0.00	0.40	0.20	2.57
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	300.82	0.00	13.97	0.00	0.00	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	196.03	0.00	18.03	0.00	0.75	0.00	0.00	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	189.64	0.00	9.32	0.53	0.80	0.27	0.00	3.20
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	312.16	0.34	36.31	0.57	0.34	0.00	0.23	0.79
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	213.65	0.74	15.47	0.00	0.00	0.00	0.00	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	276.65	0.37	30.41	1.10	1.47	0.00	0.37	1.10
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	225.56	0.00	18.67	1.56	1.56	0.00	0.00	4.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	144.30	0.53	16.03	0.53	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	162.28	0.00	27.05	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	261.57	0.00	27.27	0.00	0.00	0.00	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	122.28	0.42	9.28	0.00	0.00	0.00	0.00	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	113.04	0.00	2.72	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	76.30	0.00	8.90	1.27	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	104.47	0.00	12.96	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	61.93	0.00	10.57	1.51	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	473.94	0.00	45.68	34.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	185.96	3.26	39.15	16.31	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	304.16	0.00	28.51	4.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	414.12	0.00	37.65	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	48.26	14.00	2.15	1.72	0.00	0.43	0.00	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	28.74	6.27	0.52	0.52	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	14.02	5.34	0.00	0.67	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	21.70	2.09	0.00	0.83	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	26.05	13.69	0.95	3.04	0.00	0.00	0.19	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	38.30	20.75	0.00	3.19	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	7.48	2.72	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	66.16	20.21	0.00	7.35	0.00	0.00	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	14.65	5.02	0.42	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	26.03	6.51	0.46	0.46	0.00	0.46	0.46	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	12.43	4.59	0.00	0.81	0.00	0.00	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	30.69	8.83	0.63	0.63	0.00	0.42	0.00	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	44.54	0.00	0.00	0.00	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	17.37	4.96	0.00	0.50	0.00	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	17.59	3.79	0.00	0.54	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	15.87	4.76	0.45	0.68	0.00	0.23	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	13.72	3.27	0.00	0.49	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	32.62	3.65	0.91	1.09	0.36	0.18	0.00	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	13.79	4.77	0.53	1.06	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	9.60	3.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	22.32	11.81	0.33	0.98	0.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	14.47	4.39	0.16	1.30	0.00	0.00	0.16	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	34.92	5.47	0.71	1.23	0.35	0.00	0.18	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	11.95	3.52	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	16.55	3.68	0.46	0.46	0.46	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	14.78	3.53	0.32	1.61	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	31.38	16.21	0.69	2.76	0.00	0.34	0.34	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	111.25	35.40	2.53	12.64	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	34.31	7.13	0.22	2.01	0.00	0.22	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	21.17	2.96	0.00	1.27	0.00	0.00	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	10.21	1.90	0.00	0.47	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	14.17	6.44	0.86	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	63.19	9.03	0.00	9.03	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	20.33	5.33	0.33	1.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	28.86	7.21	0.00	0.45	0.00	0.45	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	15.48	8.33	0.79	7.94	0.00	0.40	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	17.64	3.71	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	17.78	6.43	0.00	1.89	0.00	0.38	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	19.23	6.19	0.33	0.98	0.00	0.00	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	11.77	1.74	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	34.37	9.05	1.81	6.33	0.00	0.45	0.45	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.06	6.17	1.76	4.41	0.00	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	9.97	3.99	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	13.39	6.94	0.00	1.49	0.00	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	16.84	3.06	0.77	2.30	0.00	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	29.64	4.23	0.60	1.81	0.00	0.30	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	36.91	11.71	0.66	10.61	0.00	0.66	0.44	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	13.55	5.42	2.03	7.45	0.00	0.68	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	61.31	15.33	0.00	35.77	0.00	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	14.63	3.66	0.61	1.83	0.61	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	18.88	4.41	0.31	1.57	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	19.07	0.30	0.30	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	8.70	7.91	0.00	3.16	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	32.88	12.47	2.27	13.60	0.00	2.27	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	35.41	55.64	0.00	10.12	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	47.08	10.81	1.37	2.48	0.25	0.25	0.25	0.62
Myoblast, donor2	11322-117D8	33.37	7.10	0.58	0.77	0.19	0.00	0.00	0.19
Myoblast, donor3	11398-118D3	48.60	7.74	0.67	1.68	0.34	0.00	0.17	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	126.82	0.00	3.79	0.00	0.29	0.00	0.00	1.02
Natural Killer Cells, donor1	11230-116C6	147.92	0.62	12.61	0.00	0.31	0.00	0.00	0.62
Natural Killer Cells, donor2	11311-117C6	124.24	0.60	4.52	0.00	1.81	0.00	0.00	0.90
Natural Killer Cells, donor3	11387-118C1	143.19	0.92	9.75	0.18	0.55	0.18	0.00	1.47
Neural stem cells, donor1	11275-116H6	65.33	27.58	2.18	11.98	0.00	1.45	2.18	0.00
Neural stem cells, donor2	11352-117H2	50.07	44.29	0.00	15.41	0.00	1.93	0.00	0.00
Neurons, donor1	11494-119E9	66.00	40.96	3.41	12.52	0.00	0.00	2.28	1.14
Neurons, donor2	11574-120E8	67.15	52.62	1.76	9.25	0.00	2.20	1.32	0.00
Neurons, donor3	11655-122E8	32.89	32.06	0.00	9.87	0.82	2.47	0.82	1.64
Neutrophils, donor1	11233-116C9	637.54	1.86	48.26	0.93	3.71	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	397.15	0.00	37.69	2.90	20.29	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	777.60	0.61	78.19	0.00	0.61	0.61	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	35.50	5.82	0.36	0.71	0.24	0.00	0.00	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	21.49	4.56	0.00	0.33	0.33	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	35.30	8.02	0.00	0.80	0.00	0.00	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	22.30	3.85	0.41	0.28	0.55	0.14	0.00	0.41
Olfactory epithelial cells, donor2	11934-125I8	30.40	6.22	0.58	2.17	0.87	0.14	0.14	0.14
Olfactory epithelial cells, donor3	11935-125I9	27.58	4.54	0.57	0.57	0.11	0.00	0.00	0.45
Olfactory epithelial cells, donor4	11936-126A1	38.86	6.92	1.17	0.68	0.29	0.00	0.00	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	60.78	9.63	2.41	1.81	0.60	0.60	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	31.48	5.96	0.64	0.43	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	28.58	2.29	0.00	1.14	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	16.14	2.48	0.00	0.00	0.00	0.00	0.62	0.00
Osteoblast, donor1	11277-116H8	39.48	12.12	0.98	2.35	0.00	0.00	0.00	0.39
Osteoblast, donor2	11354-117H4	61.10	15.45	2.81	2.11	0.00	0.70	0.00	0.00
Osteoblast, donor3	11426-118G4	48.70	10.66	0.53	0.89	0.71	0.18	0.18	0.00
Pancreatic stromal cells, donor1	11249-116E7	39.17	11.37	0.42	1.43	0.42	0.25	0.17	0.34
Pericytes, donor1	11491-119E6	44.17	7.90	0.56	0.11	0.00	0.11	0.00	0.00
Pericytes, donor2	11571-120E5	48.44	11.77	0.45	2.49	0.23	0.23	0.23	0.23
Pericytes, donor3	11652-122E5	60.22	6.31	1.22	0.41	0.41	0.00	0.00	0.61
Perineurial Cells, donor1	11499-119F5	51.65	9.83	2.03	0.79	0.23	0.11	0.11	0.45
Perineurial Cells, donor2	11579-120F4	44.17	7.27	0.64	1.01	0.00	0.09	0.09	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	313.00	0.00	22.63	0.64	0.32	0.00	0.00	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	212.05	0.00	14.69	0.49	4.16	0.24	0.00	1.71
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	208.10	0.39	12.68	0.00	0.13	0.00	0.00	0.26
Placental Epithelial Cells, donor1	11278-116H9	45.92	1.67	0.96	0.24	0.24	0.00	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	28.83	6.65	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	26.90	4.32	0.20	0.59	0.00	0.20	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	29.11	3.48	1.58	0.63	0.32	0.00	0.32	0.32
Preadipocyte - breast, donor1	11467-119B9	41.46	3.00	0.94	0.94	0.00	0.19	0.00	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	42.68	7.31	1.83	0.78	0.13	0.00	0.13	0.13
Preadipocyte - breast, donor2	11328-117E5	42.33	4.50	1.80	0.23	0.23	0.00	0.00	0.23
Preadipocyte - omental, donor1	11468-119C1	45.82	3.94	2.02	0.32	0.21	0.11	0.11	0.32
Preadipocyte - omental, donor2	11329-117E6	52.81	10.04	2.18	1.31	0.00	0.00	0.00	0.87
Preadipocyte - omental, donor3	11403-118D8	57.59	6.16	3.58	0.72	0.29	0.00	0.14	1.29
Preadipocyte - perirenal, donor1	11469-119C2	41.34	1.97	1.97	0.00	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	47.91	4.61	3.69	1.84	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	72.25	9.92	1.59	0.89	0.89	0.00	0.18	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	51.43	10.73	1.02	1.36	0.51	0.00	0.00	0.17
Preadipocyte - visceral, donor1	11280-116I2	64.74	17.33	0.56	2.61	0.19	0.19	0.19	0.19
Preadipocyte - visceral, donor2	11357-117H7	49.70	14.27	0.92	1.38	1.38	0.00	0.92	0.92
Preadipocyte - visceral, donor3	11429-118G7	50.26	10.55	0.94	1.36	0.42	0.00	0.00	0.52
Prostate Epithelial Cells (polarized), donor1	11253-116F2	87.04	1.66	4.22	0.45	0.00	0.00	0.00	0.45
Prostate Epithelial Cells, donor2	11331-117E8	40.22	7.99	0.68	2.30	0.41	0.27	0.14	0.54
Prostate Epithelial Cells, donor3	11404-118D9	56.46	3.12	1.78	0.24	0.43	0.00	0.00	0.98
Prostate Stromal Cells, donor1	11254-116F3	57.06	8.31	1.14	1.94	0.11	0.11	0.00	0.34
Prostate Stromal Cells, donor2	11332-117E9	56.30	10.94	1.26	1.26	0.90	0.18	0.00	0.54
Prostate Stromal Cells, donor3	11405-118E1	36.39	8.03	0.73	0.52	0.52	0.10	0.10	0.94
Renal Cortical Epithelial Cells, donor1	11516-119H4	67.52	5.47	1.46	0.36	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	61.27	7.76	1.94	0.35	0.28	0.07	0.00	0.14
Renal Epithelial Cells, donor1	11517-119H5	55.29	10.65	2.03	2.54	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	69.71	9.25	1.42	1.42	0.71	0.00	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	60.24	7.41	2.86	1.16	0.11	0.11	0.00	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	59.91	7.49	1.36	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	55.12	4.31	2.56	1.48	0.27	0.00	0.13	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	59.50	8.21	2.22	0.44	0.44	0.00	0.00	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	41.26	2.00	1.33	0.00	0.67	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	70.87	18.27	0.44	1.10	0.22	0.66	0.66	0.00
Renal Mesangial Cells, donor2	11598-120H5	57.68	10.66	0.63	1.88	0.00	0.00	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	46.05	9.43	0.55	0.83	0.00	0.00	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	111.13	7.25	4.03	1.07	0.00	0.27	0.54	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	63.25	3.37	1.27	0.42	0.42	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	66.15	11.57	1.54	1.16	0.19	0.19	0.39	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	45.63	6.48	0.78	0.78	0.00	0.00	0.00	1.56
Retinal Pigment Epithelial Cells, donor1	11528-119I7	47.75	7.96	1.42	1.14	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	40.14	7.20	0.00	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	30.61	2.51	0.25	0.00	0.00	0.00	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	91.81	4.68	2.94	2.00	0.13	0.13	0.00	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	96.49	5.36	4.47	5.36	0.89	0.00	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	59.44	9.36	1.65	8.26	0.55	1.65	1.65	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	113.11	8.70	4.06	8.12	1.16	1.16	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	167.21	12.35	5.33	4.68	0.00	1.04	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	131.98	8.94	3.48	6.16	0.50	0.20	0.30	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	171.44	13.50	5.69	6.25	0.33	1.12	0.67	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	180.11	20.96	5.46	6.45	1.24	0.99	0.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	148.25	12.70	2.21	3.38	2.33	0.82	0.35	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	180.75	13.64	4.16	6.47	0.92	0.69	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	119.11	12.18	1.37	3.70	0.14	0.55	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	127.98	9.98	3.03	4.08	0.76	0.61	0.30	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	163.78	10.57	3.94	5.38	0.00	0.36	0.72	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	130.69	9.76	2.73	4.16	0.43	0.43	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	140.05	9.77	2.79	5.47	1.29	0.86	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	164.85	15.49	4.20	7.30	0.44	0.44	0.44	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	118.91	12.81	1.91	4.97	0.19	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	141.89	11.55	3.17	4.94	0.47	0.75	0.47	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	184.90	12.40	4.32	9.21	0.38	0.56	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	143.46	10.75	3.05	3.98	0.27	0.80	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	150.78	12.85	4.77	4.48	0.78	0.10	0.10	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	162.70	8.78	3.82	7.07	1.34	0.57	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	137.66	9.08	2.78	3.10	0.21	0.75	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	135.95	14.58	5.61	6.73	0.56	0.28	0.28	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	151.07	10.94	4.61	5.13	0.51	0.68	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	140.39	10.39	3.10	3.10	0.00	0.18	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	137.84	10.42	3.43	4.66	1.47	0.37	0.49	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	162.66	13.16	3.63	4.03	0.54	0.00	0.13	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	119.35	10.85	1.18	4.01	0.71	0.24	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	137.10	9.52	4.37	3.37	0.60	0.79	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	162.52	11.93	3.04	4.44	0.70	0.70	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	122.34	8.71	1.87	3.11	0.41	0.00	0.62	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	148.43	9.29	3.10	3.98	3.10	0.66	1.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	148.10	8.15	4.18	3.76	0.42	0.21	0.21	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	125.70	8.48	2.56	4.58	0.13	0.40	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	149.01	8.17	3.41	4.94	1.19	0.34	0.51	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	151.54	10.60	4.82	5.78	0.77	0.58	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	119.50	14.10	1.55	3.09	0.00	0.34	0.86	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	135.66	10.01	3.02	4.80	0.55	0.27	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	148.90	14.12	5.09	5.75	1.48	0.82	0.49	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	108.56	16.53	0.51	5.45	0.51	0.85	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	140.56	20.42	3.85	8.29	0.59	0.59	0.15	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	126.61	17.06	3.73	7.20	0.27	0.27	0.80	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	114.35	10.92	1.80	6.22	0.28	0.55	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	133.58	11.67	2.38	8.57	0.95	0.95	0.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	147.13	18.74	3.63	10.48	0.40	2.02	1.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	103.59	14.03	2.07	11.02	0.19	0.47	0.75	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	128.91	11.88	4.19	9.08	0.70	1.40	0.35	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	113.03	13.60	2.42	13.90	0.60	1.51	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	123.24	16.28	2.69	11.26	0.37	0.61	0.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	167.82	17.61	5.09	12.52	0.58	2.33	1.31	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	141.16	12.17	3.65	13.99	1.22	0.61	1.22	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	111.52	8.14	1.51	6.33	0.00	1.21	1.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	119.88	11.08	2.71	11.99	0.90	0.23	1.58	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	153.96	16.18	3.59	16.18	0.90	0.90	1.50	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	121.62	15.35	4.01	11.34	0.35	1.06	1.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	114.83	11.31	3.42	8.96	1.28	1.28	0.43	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	129.81	14.42	1.80	15.02	0.60	2.40	1.20	1.20
Schwann Cells, donor1	11498-119F4	50.40	11.10	1.32	1.32	0.56	0.00	0.19	0.00
Schwann Cells, donor2	11578-120F3	34.02	6.80	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	37.02	9.64	0.22	1.53	0.22	0.00	0.00	1.53
Sebocyte, donor1	11220-116B5	69.02	7.12	0.55	2.19	0.00	0.55	0.00	0.55
Sebocyte, donor2	11301-117B5	35.39	5.06	0.46	0.92	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	45.55	6.60	0.82	0.82	0.00	0.00	0.21	0.21
Sertoli Cells, donor1	11255-116F4	62.95	4.97	1.66	0.00	0.00	1.66	0.00	4.97
Sertoli Cells, donor2	11333-117F1	31.07	5.65	5.65	0.00	0.00	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	49.18	8.71	0.53	0.70	0.00	0.26	0.18	0.09
Skeletal Muscle Cells, donor2	11358-117H8	32.53	5.06	0.00	4.34	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	58.52	12.54	0.84	0.84	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	41.63	6.13	0.47	0.16	0.00	0.00	0.16	0.00
Skeletal Muscle Cells, donor5	11455-119A6	38.35	4.61	0.74	1.04	0.30	0.00	0.00	0.15
Skeletal Muscle Cells, donor6	11459-119B1	46.79	5.23	1.69	1.23	0.77	0.00	0.00	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	38.56	9.95	0.13	1.01	0.38	0.00	0.00	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	34.96	9.85	0.71	0.29	0.14	0.00	0.00	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	57.14	5.95	0.89	0.79	0.40	0.10	0.20	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	50.30	21.23	0.93	13.56	0.08	1.10	0.67	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	40.53	12.30	0.72	0.00	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	33.71	14.04	0.14	1.10	0.41	0.96	0.00	0.28
Skin - palm, donor1	10286-104F7	128.93	8.06	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	35.32	3.60	2.59	0.72	0.29	0.00	0.00	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	58.07	3.27	1.64	1.64	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	31.94	2.34	0.91	0.26	0.13	0.26	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	52.68	5.00	1.67	1.39	0.70	0.00	0.28	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	38.54	4.78	0.84	0.42	0.42	0.00	0.00	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	77.39	8.46	3.38	0.42	0.00	0.00	0.21	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	53.14	3.37	0.82	0.22	0.15	0.00	0.00	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	41.97	10.49	0.00	1.85	0.62	0.00	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	37.35	10.45	0.44	0.89	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	47.61	8.23	0.00	0.59	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	48.18	7.73	1.10	1.33	0.22	0.00	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	72.46	16.14	3.15	1.97	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	52.53	5.41	0.77	0.77	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	36.03	2.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	47.38	7.59	1.06	0.93	0.13	0.40	0.00	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	53.86	8.87	0.22	3.10	0.89	0.44	0.22	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	63.63	11.65	1.54	2.56	0.64	0.13	0.26	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	28.98	7.16	0.65	0.33	0.00	0.00	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	35.73	13.58	1.48	1.18	0.00	0.00	0.30	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	41.57	6.41	0.71	0.57	0.14	0.00	0.14	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	64.26	10.09	1.14	0.49	0.16	0.33	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	36.53	7.61	0.30	0.61	0.00	0.00	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	34.35	6.06	1.01	0.51	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	6.12	0.00	0.00	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	36.72	3.34	2.86	0.48	0.00	0.95	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	40.70	4.57	0.15	0.29	0.00	0.00	0.00	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	31.42	5.17	0.22	0.86	0.86	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	36.42	6.40	0.42	0.84	0.10	0.21	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	76.72	11.29	3.56	2.47	0.15	0.46	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	73.30	7.55	5.39	4.31	0.00	0.00	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	58.28	8.67	1.20	1.20	0.00	0.30	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	60.43	10.24	2.39	2.05	0.00	0.00	0.00	1.02
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	35.73	6.52	0.55	0.16	0.08	0.00	0.08	0.63
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	42.77	14.09	1.41	3.02	0.20	0.10	0.10	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	74.86	11.61	2.50	0.68	0.68	0.00	0.00	1.59
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	41.06	5.43	1.21	0.00	0.60	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	75.77	11.66	1.32	1.59	0.00	0.53	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	48.34	10.25	0.80	1.33	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	43.20	7.64	0.25	1.63	0.13	0.38	0.00	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	24.86	4.31	0.76	0.76	0.00	0.00	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	63.02	14.78	2.56	1.81	0.00	0.45	0.00	1.06
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	36.01	11.25	0.00	0.00	0.75	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	43.94	6.46	5.17	3.88	2.58	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	42.79	6.98	0.93	1.40	0.47	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	50.49	12.62	1.51	1.01	1.51	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	44.19	10.66	2.19	1.57	0.31	0.31	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	41.00	13.86	0.59	1.47	0.29	0.29	0.59	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	60.90	12.41	1.67	0.83	0.00	0.25	0.00	0.50
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	31.77	7.94	0.00	0.00	0.00	0.00	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	56.13	9.50	2.59	2.45	0.43	0.00	0.14	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	60.68	6.63	2.04	1.27	0.00	0.25	0.00	1.27
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	44.00	6.96	1.13	0.94	0.38	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	50.31	12.44	1.40	0.42	0.00	0.00	0.00	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	45.50	8.71	1.09	0.42	0.17	0.08	0.00	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	31.43	0.48	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	55.05	6.61	1.47	1.47	0.00	0.00	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	53.47	11.71	1.33	0.22	0.22	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	31.89	7.90	0.29	1.17	0.29	0.29	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	19.24	1.75	0.19	0.00	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	29.09	5.82	0.53	1.59	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	18.23	8.55	0.00	1.49	0.74	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	34.14	8.98	0.36	3.23	0.72	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	47.41	5.96	0.57	2.27	0.28	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	36.24	7.88	0.79	0.79	0.00	0.39	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	26.92	5.08	0.51	0.51	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	17.17	3.59	0.00	0.80	0.00	0.00	0.00	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	19.65	1.67	0.00	0.42	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	21.54	1.83	0.00	1.38	0.46	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	50.83	8.25	2.19	1.35	0.17	0.00	0.00	0.17
Synoviocyte, donor2	11368-117I9	34.20	4.02	0.50	0.00	0.50	0.00	0.00	0.17
Synoviocyte, donor3	11440-118H9	26.14	5.81	0.67	0.22	0.45	0.00	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	82.19	10.72	1.07	1.43	0.00	0.36	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	35.68	9.91	1.98	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	43.53	8.57	1.16	1.16	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	40.43	3.58	0.86	0.36	0.00	0.07	0.00	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	35.95	3.09	0.39	0.39	0.39	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	31.50	1.72	1.72	0.57	0.00	0.00	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	89.93	4.55	4.43	1.85	0.49	0.37	0.25	0.37
Urethra, donor2	10319-105A4	97.12	3.60	1.80	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	55.26	8.77	2.66	0.80	0.53	0.27	0.00	0.27
Urothelial Cells, donor2	11600-120H7	34.45	4.81	0.40	0.80	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	34.61	4.35	1.15	0.92	0.46	0.00	0.00	0.46
Urothelial cells, donor0	11216-116B1	53.49	8.47	1.78	0.22	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	434.21	0.89	30.25	0.89	0.89	0.00	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	448.90	1.43	31.45	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	276.55	0.00	13.69	0.68	4.11	0.00	0.00	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	336.76	0.00	23.07	0.34	0.00	0.00	0.00	1.72
Whole blood (ribopure), donor090325, donation2	12177-128I8	338.74	0.00	24.40	0.58	0.58	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	437.32	0.00	38.53	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	385.47	0.00	19.27	0.00	0.92	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	252.87	0.00	21.91	0.00	3.65	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	65.01	3.82	3.95	0.74	0.00	0.25	0.00	0.62
Wilms' tumor cell line:HFWT	10597-108E3	77.44	1.76	1.76	1.76	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	58.38	5.87	0.00	0.84	0.28	0.00	0.00	0.28
achilles tendon, donor2	10292-104G4	90.93	0.00	4.13	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	140.48	0.25	16.32	0.25	1.02	0.00	0.00	1.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	145.57	0.46	5.34	0.23	0.00	0.00	0.00	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	124.52	3.92	5.46	1.07	0.36	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	146.94	13.61	9.80	0.82	0.27	0.00	0.00	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	129.02	0.00	3.94	0.00	0.84	0.00	0.00	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	330.33	2.54	28.34	1.06	0.42	0.00	0.00	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	178.57	1.09	8.98	0.27	1.09	0.27	0.00	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	196.52	1.32	11.02	1.32	0.44	0.00	0.00	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	167.43	0.41	7.35	0.00	0.41	0.00	0.41	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	260.16	0.00	19.41	0.00	0.39	0.00	0.00	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	142.42	0.18	3.31	0.00	1.10	0.00	0.00	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	230.13	0.00	15.60	0.00	0.00	0.00	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	117.12	1.16	6.04	0.46	0.70	0.00	0.00	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	244.14	2.85	17.61	1.04	0.78	0.26	0.26	1.81
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	270.62	0.88	17.83	1.75	1.75	0.00	0.00	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	182.65	0.00	6.51	0.46	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	151.34	0.00	6.17	0.00	1.65	0.00	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	220.70	1.53	16.88	2.76	0.00	0.31	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	287.60	5.97	13.23	3.41	0.85	0.00	0.00	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	319.06	3.03	18.20	5.76	0.30	0.00	0.30	1.52
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	314.12	2.17	19.74	6.50	0.72	0.00	0.24	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	125.85	0.00	6.01	0.22	0.45	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	82.39	2.67	2.33	0.00	0.00	0.00	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	161.66	5.57	3.72	0.00	0.00	0.00	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	169.87	0.38	8.66	0.38	1.13	0.38	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	151.77	1.74	10.03	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	134.96	1.87	5.62	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	83.37	0.94	3.77	0.00	0.00	0.24	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	97.10	3.72	2.95	1.55	0.16	0.00	0.31	0.00
adipose, donor1	10184-103D4	71.54	20.52	2.35	17.59	1.76	2.93	3.52	2.35
adipose, donor2	10185-103D5	28.79	4.87	0.81	1.62	0.00	0.00	0.00	1.62
adipose, donor3	10186-103D6	28.86	13.61	0.00	7.62	1.09	1.09	0.27	0.27
adipose, donor4	10187-103D7	39.00	19.07	0.00	5.20	0.87	2.60	1.73	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	78.91	3.63	1.89	0.79	0.16	0.00	0.16	0.00
adrenal gland, adult, pool1	10081-102A9	72.75	7.28	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	95.25	0.13	4.00	0.13	0.27	0.00	0.00	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	62.53	3.57	0.71	0.36	0.00	0.36	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	63.53	3.94	2.78	2.78	0.23	0.00	0.23	0.46
amniotic membrane cells, donor2	12236-129G4	57.48	5.07	1.01	0.68	0.00	0.00	0.00	0.34
amniotic membrane cells, donor3	12237-129G5	52.73	3.54	2.06	0.59	0.00	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	88.93	35.57	2.37	1.19	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	114.56	30.21	5.68	3.65	0.81	0.20	0.41	0.81
amygdala, newborn, donor10223	10360-105E9	80.69	15.17	3.23	16.14	0.00	0.32	0.32	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	59.85	0.76	2.16	0.00	0.00	0.00	0.00	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	74.35	0.44	1.76	0.22	0.22	0.00	0.00	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	35.74	10.36	0.67	0.67	0.00	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	65.70	7.45	2.75	1.18	0.20	0.00	0.59	0.59
appendix, adult	10189-103D9	206.87	4.66	10.48	0.00	0.00	0.00	0.00	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	62.94	23.73	0.34	7.22	0.69	0.69	0.69	0.00
artery, adult	10190-103E1	44.84	5.43	1.36	5.43	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	47.81	7.39	0.72	1.45	0.00	0.43	0.00	0.14
b cell line:RPMI1788	10427-106D4	229.30	0.59	19.48	0.30	0.45	0.00	0.45	1.93
basal cell carcinoma cell line:TE 354.T	10702-109G9	51.88	6.66	1.94	3.88	0.00	0.55	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	76.81	3.67	1.09	0.89	0.00	0.10	0.00	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	84.53	0.67	1.84	0.00	0.00	0.00	0.00	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	196.85	4.47	24.05	6.15	0.56	0.00	0.00	2.24
bladder, adult, pool1	10011-101C2	76.70	7.60	3.26	0.65	0.22	0.00	0.11	0.11
blood, adult, pool1	10053-101G8	157.24	0.00	8.86	0.00	4.43	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	43.67	5.14	0.86	1.71	0.86	0.00	0.00	0.00
bone marrow, adult	10192-103E3	118.77	4.72	4.05	2.02	2.02	0.00	0.67	0.00
brain, adult, donor1	10084-102B3	70.73	18.45	1.03	2.05	0.00	0.00	1.03	2.05
brain, adult, pool1	10012-101C3	113.25	18.93	4.01	2.12	0.56	0.11	0.11	0.33
brain, fetal, pool1	10085-102B4	85.48	56.10	0.00	5.34	0.00	2.67	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	164.52	4.29	2.31	1.32	0.66	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	428.14	47.56	45.56	179.37	0.50	4.37	4.49	3.00
breast, adult, donor1	10080-102A8	67.56	1.89	1.89	0.00	0.00	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	60.98	3.94	1.27	0.64	0.38	0.00	0.00	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	71.12	11.75	1.55	0.93	0.62	0.62	0.31	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	45.12	5.06	0.92	1.15	0.69	0.00	0.00	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	58.83	5.08	1.21	2.18	0.00	0.00	0.24	0.73
carcinoid cell line:NCI-H1770	10703-109H1	62.06	0.47	0.00	0.47	0.00	0.47	0.47	0.94
carcinoid cell line:NCI-H727	10735-110B6	52.72	1.86	0.98	0.33	0.11	0.00	0.00	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	52.60	2.85	0.63	0.00	0.00	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	41.79	10.38	0.80	0.00	0.27	0.00	0.00	0.00
caudate nucleus - adult, donor10196	10177-103C6	108.22	11.51	4.61	2.30	1.15	0.00	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	115.29	30.45	4.85	3.68	0.17	0.17	0.00	0.50
caudate nucleus, adult, donor10258	10379-105H1	74.89	14.52	3.82	1.53	0.00	0.00	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	42.12	13.18	3.30	8.79	0.73	0.37	0.00	0.73
cerebellum - adult, donor10196	10173-103C2	104.88	29.13	2.91	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	120.42	32.45	3.20	2.56	1.49	0.00	0.00	0.64
cerebellum, adult, pool1	10083-102B2	71.06	20.01	0.34	1.72	0.00	0.34	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	87.18	45.67	4.15	16.61	0.83	1.66	0.00	0.83
cerebral meninges, adult	10188-103D8	123.80	18.66	4.79	0.76	1.01	0.50	0.25	0.76
cerebrospinal fluid, donor2	10294-104G6	67.24	2.19	5.12	1.46	0.73	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	93.75	2.30	2.88	0.72	0.14	0.00	0.00	0.43
cervical cancer cell line:ME-180	10553-107I4	74.24	3.31	5.47	2.82	0.00	0.00	0.00	0.17
cervix, adult, pool1	10013-101C4	75.91	6.09	2.41	0.42	0.42	0.00	0.00	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	54.20	3.20	1.67	1.11	0.00	0.00	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	32.66	5.23	2.61	0.00	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	203.69	0.12	12.43	0.12	1.37	0.00	0.00	0.25
choriocarcinoma cell line:SCH	10785-110H2	153.15	5.17	6.65	1.36	0.37	0.12	0.12	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	108.63	2.61	4.27	1.19	0.00	0.24	0.00	0.95
chorionic membrane cells, donor1	12238-129G6	101.72	4.56	4.27	4.27	0.00	0.00	0.00	0.57
chorionic membrane cells, donor2	12239-129G7	74.57	9.94	2.29	2.09	0.10	0.10	0.20	1.19
chorionic membrane cells, donor3	12240-129G8	145.61	4.95	6.59	4.40	1.65	0.55	0.00	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	83.81	0.00	10.10	1.01	5.05	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	120.25	0.58	5.19	0.19	0.19	0.00	0.00	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	103.06	0.42	1.69	0.63	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	79.09	0.26	1.03	0.00	0.26	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	82.72	0.48	1.21	0.24	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	81.85	0.20	3.66	0.20	0.20	0.00	0.00	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	90.10	0.29	3.24	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	176.44	1.56	3.65	0.26	0.26	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	60.57	4.34	1.60	0.00	0.46	0.00	0.00	0.91
clear cell carcinoma cell line:TEN	10636-108I6	55.00	1.21	2.43	0.69	0.00	0.00	0.52	0.35
colon carcinoma cell line:CACO-2	10513-107D9	113.49	4.94	3.11	2.56	0.00	0.18	0.00	0.37
colon carcinoma cell line:COLO-320	10420-106C6	91.22	24.71	2.66	5.32	0.00	1.14	0.76	0.38
colon, adult, donor1	10082-102B1	90.44	8.33	0.00	0.00	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	90.83	8.11	3.88	1.53	0.00	0.12	0.12	0.00
colon, fetal, donor1	10070-101I7	71.69	5.56	0.62	0.00	0.00	0.00	0.00	1.24
common myeloid progenitor CMP, donor1	12130-128D6	692.11	0.00	18.33	0.00	0.00	0.00	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	175.26	0.00	25.04	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	90.94	0.00	5.10	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	107.46	0.00	3.32	0.00	0.15	0.00	0.00	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	118.45	0.14	3.95	0.14	0.42	0.00	0.00	0.28
corpus callosum, adult, pool1	10042-101F6	118.08	32.73	2.87	2.65	0.33	0.44	0.11	0.33
cruciate ligament, donor2	10295-104G7	101.31	2.43	4.05	0.00	0.81	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	56.98	10.43	4.01	2.41	0.00	0.00	0.80	0.00
diencephalon, adult	10193-103E4	79.92	17.28	1.92	1.92	0.72	0.24	0.24	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	135.24	0.00	11.25	0.23	2.07	0.00	0.00	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	110.01	1.28	4.36	0.00	0.51	0.00	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	50.55	5.78	0.96	0.96	0.48	0.00	0.00	0.24
ductus deferens, adult	10196-103E7	68.27	11.46	0.50	0.50	1.50	0.00	0.00	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	57.61	5.76	0.00	0.00	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	90.48	13.24	2.21	0.00	2.94	0.00	0.00	0.00
dura mater, adult, donor1	10041-101F5	186.48	3.63	21.97	0.74	0.74	0.25	0.08	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	76.17	5.55	5.55	6.88	0.44	0.44	0.22	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	85.55	6.02	2.58	3.30	0.29	0.57	0.57	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	87.56	0.00	1.23	0.62	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	72.05	1.82	0.91	0.91	0.91	0.00	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	85.83	0.62	1.54	0.31	0.00	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	94.57	0.00	2.63	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	132.40	8.72	1.01	1.34	0.00	0.34	1.01	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	81.56	13.05	2.54	2.36	0.18	0.00	0.18	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	79.12	4.18	2.89	1.45	0.48	0.00	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	81.26	6.89	1.89	1.00	0.11	0.22	0.33	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	99.98	2.53	2.97	0.33	0.22	0.11	0.00	0.11
epididymis, adult	10197-103E8	71.17	4.81	3.56	1.67	1.26	0.00	0.00	1.05
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	59.08	7.10	2.48	1.60	0.35	0.00	0.00	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	36.18	1.97	0.00	0.00	0.79	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	84.13	0.26	5.24	0.00	0.26	0.00	0.13	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	85.23	0.59	4.13	0.10	0.89	0.00	0.00	0.98
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	81.11	0.34	3.81	0.22	0.90	0.00	0.00	1.01
esophagus, adult, pool1	10015-101C6	72.41	7.22	2.87	1.06	0.11	0.11	0.21	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	88.04	4.38	1.50	0.63	0.13	0.00	0.00	0.38
eye - muscle inferior rectus, donor1	10272-104E2	72.44	2.41	7.24	7.24	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	101.00	2.10	0.00	6.31	2.10	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	93.76	1.49	2.98	2.98	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	94.01	5.73	1.15	0.00	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	96.19	2.91	2.91	1.46	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	47.03	12.71	2.29	2.80	0.25	0.00	0.25	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	36.80	1.54	0.13	0.00	0.00	0.00	0.00	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	74.07	2.85	1.19	0.47	0.00	0.00	0.00	0.71
frontal lobe, adult, pool1	10040-101F4	121.50	34.34	2.53	3.28	0.47	0.47	0.09	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	87.67	8.41	2.10	2.40	0.00	0.00	0.00	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	68.58	7.31	1.65	0.00	0.00	0.00	0.00	0.18
gall bladder, adult	10198-103E9	75.33	4.83	2.90	0.24	1.21	0.24	0.00	0.00
gamma delta positive T cells, donor1	11937-126A2	138.51	0.54	3.76	0.00	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	143.79	0.75	5.60	0.37	0.00	0.00	0.00	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	32.32	2.96	1.48	0.84	0.21	0.00	0.00	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	94.19	0.58	1.74	0.19	0.58	0.19	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	149.36	8.69	3.44	2.13	0.16	0.33	0.16	0.00
gastric cancer cell line:GSS	10560-108A2	59.49	2.75	0.92	0.92	0.00	0.00	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	64.42	1.37	1.60	0.46	1.83	0.00	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	70.34	0.11	1.26	0.11	0.11	0.00	0.00	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	62.42	7.14	0.70	1.54	0.14	0.14	0.28	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	79.56	2.00	3.74	1.25	0.00	0.00	0.25	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	50.03	9.39	2.01	2.01	0.11	0.42	0.11	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	57.72	12.22	2.53	1.54	0.00	0.42	0.28	0.28
glioblastoma cell line:T98G	10485-107A8	50.22	5.74	1.32	1.77	0.11	0.33	0.00	0.33
glioma cell line:GI-1	10413-106B8	56.82	8.79	2.05	2.05	0.00	0.00	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	94.03	13.85	3.64	0.73	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	173.80	20.02	7.32	2.20	0.73	0.49	0.00	1.22
globus pallidus, adult, donor10258	10367-105F7	50.66	8.22	2.74	6.85	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	61.29	11.72	4.80	3.73	1.07	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	1289.64	0.00	88.10	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	251.35	0.00	32.79	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	167.25	0.00	15.68	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	32.96	9.60	0.96	0.64	0.00	0.32	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	57.39	11.48	0.92	6.43	0.46	2.30	0.92	0.00
hIPS +CCl2, biol_rep2	14384-156C1	66.30	8.23	1.37	4.12	0.00	0.00	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	67.63	8.37	0.64	3.22	0.00	1.29	0.00	0.00
hIPS, biol_rep1	14380-156B6	43.12	10.06	2.87	18.68	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	58.98	5.49	1.37	5.49	0.69	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	72.83	19.86	1.10	1.10	0.00	0.00	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	153.44	1.15	9.19	0.29	0.29	0.00	0.00	1.15
heart - mitral valve, adult	10205-103F7	53.81	9.27	2.09	2.09	0.30	0.00	0.00	0.30
heart - pulmonic valve, adult	10206-103F8	62.23	8.89	1.05	1.05	0.00	0.00	0.26	0.00
heart - tricuspid valve, adult	10207-103F9	79.10	1.67	0.83	0.00	0.00	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	64.89	5.31	1.22	2.24	1.02	0.00	0.00	0.20
heart, adult, diseased, donor1	10051-101G6	79.63	5.96	1.70	1.70	1.28	0.00	0.43	0.43
heart, adult, pool1	10016-101C7	90.84	4.14	0.69	3.22	0.00	0.23	0.23	0.00
heart, fetal, pool1	10046-101G1	79.27	14.79	2.26	2.98	0.31	0.21	0.21	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	59.24	6.48	2.47	0.93	0.00	0.62	0.31	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	48.76	0.00	2.38	1.19	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	134.69	11.49	6.85	6.30	1.33	0.33	0.11	2.76
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	147.71	15.90	7.89	5.34	0.97	0.61	0.12	1.94
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	148.75	13.44	7.58	7.38	0.61	0.51	0.51	2.73
hepatoma cell line:Li-7	10484-107A7	94.20	2.22	1.67	1.22	0.33	0.11	0.11	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	97.08	0.40	3.32	0.00	0.40	0.00	0.00	0.10
hippocampus - adult, donor10196	10169-103B7	100.31	30.28	4.73	0.00	0.00	0.00	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	100.21	23.27	4.29	1.63	0.61	0.20	0.41	1.22
hippocampus, adult, donor10258	10374-105G5	121.00	14.44	0.00	0.50	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	71.55	13.75	2.47	7.05	1.06	0.00	0.35	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	84.84	17.09	3.05	12.82	2.44	1.22	1.83	4.27
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	62.44	8.44	3.34	8.84	0.59	0.39	0.59	2.75
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	58.40	12.19	0.51	9.14	0.51	0.76	0.76	2.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	33.83	6.77	0.56	9.02	0.56	4.51	0.56	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	33.05	7.23	0.77	11.62	2.32	2.07	1.29	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	48.21	10.25	0.76	11.39	0.76	0.38	0.76	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	27.74	15.18	0.00	14.01	0.00	0.88	1.46	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	30.81	13.14	1.08	7.32	0.43	0.65	0.65	2.15
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	30.86	11.68	0.83	10.43	0.00	0.83	0.83	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	38.83	18.94	0.24	5.68	0.24	0.47	0.71	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	33.11	14.95	0.64	6.59	0.64	0.48	0.16	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	45.78	16.16	1.35	6.73	0.67	0.00	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	63.38	10.02	1.88	7.20	0.63	0.63	0.47	1.56
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	64.85	5.40	2.95	6.88	0.98	1.97	0.00	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	60.22	15.71	5.24	8.73	1.75	0.87	2.62	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	40.47	7.25	1.15	8.78	0.76	2.86	0.95	1.34
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	40.99	8.29	0.87	6.98	0.00	1.31	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	38.98	7.50	1.50	8.50	0.50	1.00	1.00	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	35.79	6.97	1.32	2.07	0.57	0.38	0.38	1.13
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	32.28	6.82	0.91	3.64	0.45	0.00	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	35.40	7.20	0.94	2.19	0.31	0.00	0.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	27.76	15.02	0.49	3.92	0.65	0.33	0.16	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	28.16	15.97	2.03	3.48	0.58	1.16	0.58	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	23.61	15.54	0.90	4.78	0.90	0.00	0.00	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	54.31	9.24	1.48	7.39	0.18	0.55	0.37	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	55.35	9.70	2.57	7.42	0.86	0.57	0.57	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	77.58	17.15	2.45	16.74	0.41	1.63	0.41	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	42.25	7.39	0.70	4.93	0.70	2.11	1.06	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	29.14	4.75	0.63	6.33	0.63	0.63	0.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	42.37	7.26	1.51	5.45	0.61	0.61	0.91	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	25.34	19.13	1.03	6.21	0.52	0.00	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	23.25	12.62	0.66	6.64	0.66	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	26.42	13.08	0.77	4.87	0.26	0.77	0.51	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	31.96	12.53	1.28	5.11	1.02	0.77	1.02	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	30.29	18.17	0.76	9.84	0.76	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	27.22	15.46	0.67	5.71	0.67	1.34	0.34	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	58.69	9.42	0.97	6.52	0.24	0.97	1.21	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	66.40	14.71	1.78	10.70	1.78	0.89	0.45	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	50.24	10.24	0.98	4.88	2.44	0.49	2.44	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	39.12	8.86	2.14	8.25	0.61	1.53	1.22	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	175.68	35.79	0.00	55.31	13.01	6.51	6.51	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	51.63	7.94	0.99	18.53	1.99	1.65	1.32	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	26.27	14.23	0.55	4.93	0.55	0.00	1.64	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	25.69	9.77	1.09	3.26	0.36	0.00	0.00	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	25.98	7.12	0.36	8.19	1.42	0.71	0.71	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	22.67	9.55	1.19	3.58	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	36.02	19.50	0.81	6.77	0.54	1.22	0.14	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	23.71	12.93	0.81	5.12	0.81	1.08	0.00	0.00
immature langerhans cells, donor1	11904-125F5	192.26	0.73	7.75	0.00	0.00	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	122.78	0.79	5.54	0.00	0.79	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	139.02	36.53	4.16	3.69	0.47	0.28	0.28	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	55.93	2.93	0.65	0.65	0.33	0.00	0.33	0.00
kidney, adult, pool1	10017-101C8	89.61	5.41	4.01	1.40	0.40	0.00	0.10	0.70
kidney, fetal, pool1	10045-101F9	79.79	8.84	2.26	2.05	0.14	0.00	0.00	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	114.47	4.54	2.84	0.85	0.00	0.00	0.00	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	35.80	1.24	0.28	0.14	0.14	0.00	0.00	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	74.87	1.28	1.83	0.73	0.00	0.00	0.18	0.55
left atrium, adult, donor1	10079-102A7	40.32	13.62	3.27	4.36	0.54	0.54	0.54	0.00
left ventricle, adult, donor1	10078-102A6	43.99	2.53	3.03	0.51	0.51	0.00	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	58.28	6.57	1.09	5.47	0.00	0.82	0.00	0.27
leiomyoma cell line:10964C	10569-108B2	35.21	11.86	1.08	1.08	0.72	0.36	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	35.33	10.33	2.72	4.35	2.17	0.00	0.54	0.00
leiomyoma cell line:15425	10571-108B4	36.67	11.41	0.24	1.46	0.73	0.24	0.00	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	6.35	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	69.01	4.18	3.14	0.00	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	100.59	1.89	3.78	0.47	0.35	0.12	0.00	0.47
liposarcoma cell line:KMLS-1	10782-110G8	49.05	10.93	1.72	0.94	0.31	0.62	0.31	0.00
liposarcoma cell line:SW 872	10726-110A6	64.94	8.77	2.19	0.97	0.24	0.12	0.12	0.12
liver, adult, pool1	10018-101C9	93.51	1.78	2.43	0.65	0.65	0.00	0.16	0.00
liver, fetal, pool1	10086-102B5	58.32	0.94	7.53	0.94	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	72.47	15.60	3.35	2.48	0.58	0.15	0.29	0.58
locus coeruleus, adult, donor10252	10165-103B3	105.38	16.79	5.17	1.29	0.37	0.18	0.00	0.55
locus coeruleus, adult, donor10258	10375-105G6	45.14	11.85	1.41	3.10	0.85	0.28	0.00	0.28
locus coeruleus, newborn, donor10223	10362-105F2	67.72	12.62	2.52	6.73	0.00	0.00	0.00	0.42
lung adenocarcinoma cell line:A549	10499-107C4	52.04	1.11	1.25	0.14	0.00	0.00	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	57.22	0.69	0.69	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	76.85	3.16	1.32	0.40	0.13	0.00	0.00	0.00
lung, adult, pool1	10019-101D1	119.90	1.65	5.67	0.12	0.59	0.12	0.12	0.24
lung, fetal, donor1	10068-101I5	109.88	7.71	5.42	0.86	0.29	0.00	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	110.43	3.21	11.00	0.46	0.92	0.00	0.00	0.46
lymph node, adult, donor1	10077-102A5	143.43	3.31	7.57	0.00	0.95	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	119.45	0.44	11.84	0.00	0.22	0.00	0.00	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	221.11	1.21	24.45	0.15	1.36	0.00	0.30	0.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	65.41	5.10	2.55	4.25	0.00	0.00	0.00	0.85
mature adipocyte, donor1	12231-129F8	120.77	11.99	4.00	3.55	0.44	0.00	0.00	0.44
mature adipocyte, donor2	12232-129F9	96.50	9.96	4.98	6.43	0.00	0.21	0.21	0.00
mature adipocyte, donor3	12233-129G1	82.73	10.19	1.66	4.27	0.71	0.71	0.71	0.24
mature adipocyte, donor4	12234-129G2	78.18	11.58	2.37	3.69	0.26	0.00	0.79	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	62.66	5.72	0.48	1.67	0.00	0.48	0.00	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	107.16	25.94	3.38	1.13	1.13	0.00	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	105.75	23.91	4.60	1.84	0.55	0.00	0.37	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	73.39	16.52	2.86	1.59	0.32	0.00	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	139.46	28.57	5.97	32.41	4.26	0.85	0.85	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	89.10	29.03	2.70	3.71	4.39	0.00	0.51	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	114.81	23.56	5.73	1.91	1.06	0.21	0.00	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	73.20	13.48	1.93	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	100.48	14.35	0.00	14.35	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	106.96	18.66	5.74	14.00	0.36	0.36	2.15	0.36
medulla oblongata - adult, donor10196	10174-103C3	68.79	12.98	3.24	1.95	0.00	0.65	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	117.96	15.02	6.19	1.55	0.46	0.00	0.15	1.39
medulla oblongata, adult, pool1	10038-101F2	109.05	24.24	5.14	4.00	0.16	0.41	0.73	0.16
medulla oblongata, newborn, donor10223	10361-105F1	67.70	8.33	3.82	1.39	1.04	0.35	0.00	1.04
medulloblastoma cell line:D283 Med	10838-111E1	246.43	5.76	15.72	8.41	1.33	0.22	0.22	0.89
medulloblastoma cell line:ONS-76	10759-110E3	64.44	4.77	2.45	1.35	0.00	0.00	0.12	0.24
melanoma cell line:COLO 679	10514-107E1	71.44	4.60	2.59	1.15	0.00	0.00	0.00	0.29
melanoma cell line:G-361	10465-106H6	49.13	1.90	1.09	0.27	0.27	0.00	0.00	0.27
meningioma cell line:HKBMM	10691-109F7	35.82	0.36	0.54	0.36	1.09	0.00	0.00	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	112.79	18.50	3.52	5.29	0.88	0.88	1.76	3.52
merkel cell carcinoma cell line:MS-1	10844-111E7	128.57	33.70	3.63	19.96	0.78	2.07	1.30	3.37
mesenchymal precursor cell - adipose, donor1	11747-123G1	51.86	13.66	1.53	1.23	1.07	0.00	0.00	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	34.54	6.54	0.73	0.36	0.18	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	32.71	7.45	0.41	1.66	0.83	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	34.98	13.35	1.12	0.56	0.00	0.00	0.14	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	36.78	13.29	0.39	0.39	0.00	0.00	0.00	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	27.07	15.96	0.69	2.78	0.00	0.00	0.00	2.78
mesenchymal precursor cell - cardiac, donor1	11752-123G6	42.22	2.57	1.37	0.34	0.34	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	45.43	5.98	0.23	0.58	0.35	0.00	0.12	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	46.82	8.89	1.06	0.80	0.40	0.00	0.00	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	52.40	9.05	1.22	1.08	0.41	0.14	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	67.29	9.82	1.42	1.28	0.28	0.14	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	33.59	1.65	0.33	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	54.80	8.99	1.80	1.11	0.28	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	47.82	10.82	2.09	2.09	0.00	0.35	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	43.69	10.41	0.61	0.41	0.20	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	33.79	4.67	1.08	1.08	0.00	0.36	0.00	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	25.86	9.62	0.31	0.00	0.10	0.00	0.00	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	33.06	7.30	0.91	3.19	0.23	0.00	0.46	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	74.26	21.82	0.84	2.10	0.42	0.00	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	40.80	9.41	0.45	0.75	0.15	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	41.84	9.28	0.35	0.53	0.18	0.18	0.00	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	33.13	3.31	1.10	0.37	0.74	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	44.93	4.58	0.57	0.29	0.57	0.00	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	39.15	9.68	2.53	2.53	0.84	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	34.25	8.68	0.91	1.37	0.00	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	26.35	7.42	0.51	0.51	0.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	36.12	9.42	0.52	0.26	0.79	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	29.88	8.63	0.31	1.23	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	28.71	6.59	0.47	0.47	0.47	0.00	0.00	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	37.23	7.45	0.68	0.68	0.34	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	29.08	7.86	0.00	0.00	0.00	0.39	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	25.95	8.34	0.46	0.93	0.00	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	34.90	11.54	0.29	1.15	0.29	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	30.12	9.59	0.45	1.12	0.45	0.00	0.22	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	36.05	10.58	0.24	0.72	0.48	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	30.07	13.20	0.73	0.00	0.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	23.50	6.38	1.68	1.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	30.70	7.78	0.82	0.41	0.00	0.00	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	30.93	6.44	0.43	1.29	0.00	0.00	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	30.08	10.94	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	5.16	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	25.01	12.67	0.32	1.95	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	18.91	7.27	0.00	2.91	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	23.46	7.46	0.53	1.07	0.53	0.00	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	28.62	2.45	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	21.77	7.00	1.17	0.78	0.78	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	16.79	4.20	0.00	2.10	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	26.82	6.95	1.99	0.00	0.00	0.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	28.60	0.00	0.00	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	26.09	7.71	0.59	0.00	1.19	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	30.46	7.31	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	25.97	7.60	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	21.38	3.10	0.34	0.69	0.00	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	23.64	2.15	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	6.89	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	21.60	1.22	0.41	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	20.66	3.18	0.00	0.79	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	24.17	1.18	0.59	0.59	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	21.20	2.18	0.62	0.31	0.62	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	29.41	5.35	1.34	0.00	0.00	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	35.48	0.00	0.00	2.37	1.18	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	41.09	2.57	0.00	5.14	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	34.42	5.51	1.38	1.38	0.69	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	64.82	11.88	1.48	11.88	0.99	1.48	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	63.93	8.97	5.61	5.61	1.12	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	61.06	8.27	6.36	12.09	0.64	1.27	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	76.57	9.27	3.22	24.98	0.81	1.21	1.61	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	76.32	13.08	2.18	23.99	0.00	0.00	2.18	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	69.69	5.07	5.07	24.07	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	71.61	4.86	3.64	7.28	0.00	0.61	2.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	81.34	9.04	4.52	18.08	0.00	0.00	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	62.60	4.94	4.94	10.71	0.00	1.65	0.82	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	30.76	7.74	0.40	5.16	0.20	0.40	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	32.12	4.87	0.97	5.84	0.65	0.00	0.00	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	45.84	2.04	1.02	4.07	0.00	0.00	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	68.09	9.28	4.64	0.77	0.00	0.00	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	97.80	3.78	0.94	0.94	0.00	0.00	0.00	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	67.42	13.67	2.78	5.10	0.00	0.70	0.46	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	72.65	12.82	4.27	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	59.49	13.15	3.70	5.03	0.62	0.31	0.31	0.31
mesothelioma cell line:Mero-25	10850-111F4	49.93	0.45	0.91	0.68	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	45.23	1.47	1.71	0.49	0.00	0.24	0.00	0.49
mesothelioma cell line:Mero-48a	10852-111F6	57.13	4.21	3.76	0.44	0.44	0.00	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	55.71	4.20	2.37	1.05	0.00	0.00	0.00	0.26
mesothelioma cell line:Mero-83	10854-111F8	77.62	9.36	2.89	2.55	0.51	0.00	0.68	0.17
mesothelioma cell line:Mero-84	10855-111F9	74.57	10.36	2.02	1.77	0.51	0.51	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	45.55	4.76	2.28	0.41	0.00	0.00	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	78.35	7.12	2.48	0.50	0.66	0.00	0.00	0.50
mesothelioma cell line:NCI-H226	10846-111E9	64.80	3.62	2.90	0.36	0.18	0.00	0.18	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	33.99	2.39	0.85	0.34	0.00	0.00	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	63.36	8.91	1.78	4.07	0.51	0.51	0.00	0.25
mesothelioma cell line:No36	10857-111G2	55.78	2.61	2.61	0.00	0.33	0.00	0.00	0.65
mesothelioma cell line:ONE58	10858-111G3	49.86	0.54	1.35	0.27	0.27	0.00	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	160.06	6.14	4.41	0.96	0.58	0.00	0.00	0.38
migratory langerhans cells, donor2	11902-125F3	140.80	3.66	7.20	1.10	0.37	0.12	0.00	0.24
migratory langerhans cells, donor3	11903-125F4	152.02	0.72	7.36	0.36	0.00	0.00	0.00	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	63.34	1.31	1.31	0.00	1.96	0.00	0.00	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	39.84	4.24	1.06	0.42	0.21	0.21	0.00	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	52.29	4.38	1.61	0.46	0.00	0.23	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	103.90	1.52	7.23	0.19	0.38	0.19	0.00	0.76
myelodysplastic syndrome cell line:SKM-1	10772-110F7	212.70	0.18	12.01	0.18	1.29	0.00	0.18	1.11
myeloma cell line:PCM6	10474-106I6	199.84	0.20	15.22	0.20	0.59	0.00	0.00	0.99
myxofibrosarcoma cell line:MFH-ino	10600-108E6	37.54	3.04	0.00	0.00	0.00	0.51	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	87.48	6.08	1.77	0.39	0.00	0.00	0.20	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	58.50	2.56	1.11	0.11	0.11	0.00	0.00	0.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	47.95	2.13	1.54	0.07	0.22	0.00	0.07	0.51
nasal epithelial cells, donor2	12227-129F4	49.13	2.21	2.76	0.00	1.10	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	111.12	49.69	1.15	24.16	0.23	3.91	2.30	0.23
neuroblastoma cell line:NB-1	10539-107G8	98.03	57.81	3.18	16.46	0.19	3.93	1.68	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	53.99	9.28	1.90	2.53	1.05	0.00	0.42	0.63
neuroblastoma cell line:NH-12	10555-107I6	80.69	27.39	2.42	7.83	0.19	1.12	0.56	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	23.96	10.91	0.95	0.71	0.71	0.24	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	38.64	6.97	1.27	3.17	1.11	0.32	0.16	0.95
neuroectodermal tumor cell line:TASK1	10774-110F9	36.43	6.44	0.81	1.41	0.20	0.60	0.40	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	57.85	8.90	0.64	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	42.85	9.58	0.53	0.80	0.00	0.00	0.00	0.27
neutrophil PMN, donor1	12133-128D9	1829.60	0.00	163.62	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	438.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	284.12	0.00	9.47	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	120.58	1.86	4.57	0.68	0.17	0.00	0.00	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	93.66	43.23	0.80	20.81	0.80	4.00	2.40	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	32.38	8.66	0.32	1.60	0.32	0.64	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	44.67	16.55	2.10	6.83	0.53	0.53	0.26	1.31
nucleus accumbens, adult, pool1	10037-101F1	121.11	31.12	3.84	3.19	0.28	0.37	0.19	0.56
occipital cortex - adult, donor10196	10172-103C1	117.44	10.30	4.12	2.06	0.00	0.00	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	131.23	18.25	7.51	1.61	0.81	0.27	0.27	1.34
occipital cortex, newborn, donor10223	10355-105E4	104.45	15.65	6.19	13.83	1.09	1.09	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	102.60	21.25	2.36	1.31	1.05	0.26	0.26	2.10
occipital lobe, fetal, donor1	10073-102A1	78.95	111.57	2.57	28.75	1.72	4.29	2.57	0.00
occipital pole, adult, pool1	10036-101E9	122.52	23.65	3.00	1.73	0.00	0.24	0.24	0.00
olfactory region, adult	10195-103E6	92.66	22.54	2.48	1.72	0.19	0.00	0.19	0.76
optic nerve, donor1	10277-104E7	116.06	24.01	2.00	2.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	115.16	7.40	2.39	3.76	0.34	0.34	0.11	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	47.67	1.92	0.14	0.27	0.14	0.00	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	52.32	3.56	1.35	0.51	0.85	0.00	0.00	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	59.26	2.19	1.39	0.35	0.12	0.00	0.00	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	31.75	3.82	0.59	0.88	0.00	0.59	0.00	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	75.68	1.87	1.87	0.00	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	25.24	4.45	0.42	1.48	0.21	0.21	0.00	0.00
ovary, adult, pool1	10020-101D2	73.72	1.83	2.01	0.00	0.00	0.00	0.00	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	56.83	4.95	1.65	0.37	0.18	0.00	0.00	0.18
pancreas, adult, donor1	10049-101G4	48.91	1.88	1.88	0.00	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	112.09	0.00	2.80	0.28	0.00	0.00	0.00	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	61.33	3.41	1.53	0.85	1.19	0.00	0.00	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	85.44	3.97	2.15	0.66	0.17	0.00	0.17	0.00
paracentral gyrus, adult, pool1	10035-101E8	128.04	30.66	3.11	1.19	0.46	0.37	0.09	0.27
parietal cortex, adult, donor10258	10373-105G4	79.27	6.61	0.73	0.73	0.00	1.47	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	74.30	22.57	0.94	0.94	0.00	0.94	0.94	2.82
parietal lobe, adult, donor10252	10157-103A4	107.17	20.24	3.14	1.71	0.29	0.29	0.00	1.14
parietal lobe, adult, pool1	10034-101E7	116.76	27.32	2.11	2.11	0.35	0.09	0.09	0.26
parietal lobe, fetal, donor1	10072-101I9	61.10	75.65	0.97	12.61	0.00	1.94	1.94	0.97
parietal lobe, newborn, donor10223	10356-105E5	109.54	22.43	5.23	19.44	0.75	0.37	1.50	1.12
parotid gland, adult	10199-103F1	75.85	2.47	0.62	0.62	3.08	0.00	0.00	0.00
penis, adult	10200-103F2	49.41	4.30	1.61	2.15	0.00	0.00	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	44.07	1.49	1.86	0.19	0.19	0.00	0.00	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	73.28	3.50	0.87	0.58	0.29	0.00	0.00	0.73
pineal gland - adult, donor10196	10179-103C8	48.38	11.61	2.58	3.23	0.65	1.94	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	87.06	30.80	2.37	4.74	0.00	0.00	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	37.00	13.80	1.88	3.76	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	75.89	15.18	0.00	2.02	1.01	0.00	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	130.29	20.85	3.65	2.08	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	59.59	12.77	2.55	0.85	0.85	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	94.92	8.92	4.62	5.81	0.22	0.22	0.00	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	131.24	0.00	10.46	0.40	0.53	0.00	0.00	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	40.93	4.67	0.93	0.47	0.16	0.00	0.16	0.00
pons, adult, pool1	10033-101E6	96.74	16.35	3.27	1.20	0.26	0.09	0.09	0.34
postcentral gyrus, adult, pool1	10032-101E5	126.40	23.10	2.53	2.18	0.17	0.52	0.35	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	1001.78	0.00	56.47	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	126.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	70.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	80.41	5.97	2.62	2.33	0.00	0.15	0.00	0.29
prostate cancer cell line:PC-3	10439-106E7	190.40	15.06	4.72	4.90	0.36	0.54	0.54	1.27
prostate, adult, pool1	10022-101D4	73.91	6.62	1.63	0.91	0.00	0.00	0.00	0.18
putamen, adult, donor10196	10176-103C5	146.83	47.92	6.85	3.54	0.47	0.47	0.24	1.18
putamen, adult, donor10252	10152-102I8	135.29	13.73	3.92	0.00	1.96	0.00	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	79.78	3.28	4.37	7.65	0.00	1.09	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	115.25	11.84	3.38	0.48	0.24	0.24	0.00	0.48
putamen, newborn, donor10223	10365-105F5	45.73	19.49	1.50	11.24	0.75	0.75	0.00	2.25
rectal cancer cell line:TT1TKB	10469-106I1	83.50	1.45	2.33	0.58	0.00	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	84.85	37.56	4.17	4.17	1.39	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	50.67	6.15	1.70	0.64	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	57.99	0.83	0.83	0.00	0.00	0.00	0.00	0.83
retina, adult, pool1	10030-101E3	93.14	13.22	1.79	2.98	0.20	0.10	0.10	0.30
retinoblastoma cell line:Y79	10475-106I7	74.30	15.07	2.08	9.61	0.78	0.78	1.04	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	54.22	5.29	1.23	1.23	0.00	0.00	0.12	0.61
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	123.17	10.69	3.37	0.56	0.28	0.00	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	43.20	6.82	0.76	0.76	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	26.71	3.24	1.13	0.65	0.00	0.00	0.16	0.00
salivary acinar cells, donor2	11772-123I8	28.23	3.03	0.28	0.69	0.14	0.14	0.00	0.00
salivary acinar cells, donor3	11773-123I9	55.61	1.99	3.31	0.00	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	92.66	1.72	0.57	1.14	0.00	0.00	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	60.70	2.61	0.08	0.08	0.17	0.00	0.00	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	59.72	1.88	1.41	0.00	0.12	0.00	0.12	0.12
seminal vesicle, adult	10201-103F3	68.25	6.35	1.59	2.12	0.53	0.00	1.06	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	54.90	2.67	1.46	0.00	0.49	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	46.55	2.01	1.76	1.26	0.75	0.00	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	81.29	4.01	1.00	2.01	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	168.98	0.40	4.57	0.00	0.54	0.13	0.13	1.07
signet ring carcinoma cell line:Kato III	10436-106E4	96.93	0.88	1.77	0.33	0.22	0.11	0.00	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	128.51	2.84	5.55	0.77	0.52	0.00	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	55.33	9.93	0.71	7.09	0.00	0.00	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	55.53	4.92	2.04	2.64	0.24	0.24	0.24	0.24
skeletal muscle, fetal, donor1	10066-101I3	46.23	26.13	0.00	16.08	1.01	0.00	1.01	0.00
skin, adult, donor1	10074-102A2	54.28	0.00	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	60.60	7.57	1.26	4.42	0.00	0.00	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	70.04	10.01	4.67	3.67	0.33	1.00	0.67	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	60.20	24.90	1.58	38.77	1.26	2.84	0.95	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	86.16	8.87	3.08	1.54	0.39	0.00	0.19	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	100.71	27.20	3.63	29.50	0.00	3.79	2.31	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	69.33	3.86	2.41	0.16	0.48	0.32	0.00	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	46.20	9.59	0.87	5.01	0.00	0.87	0.87	0.22
small intestine, adult, pool1	10024-101D6	125.89	6.93	7.52	0.84	0.12	0.00	0.12	0.84
small intestine, fetal, donor1	10064-101I1	62.16	9.09	2.46	0.25	0.74	0.00	0.00	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	38.47	1.54	3.08	0.00	1.03	0.51	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	57.12	16.28	1.55	0.00	0.52	0.00	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	60.84	2.95	1.88	1.88	0.27	0.27	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	78.23	15.83	6.42	3.21	1.38	0.46	0.23	0.46
spinal cord, adult, donor10252	10159-103A6	132.87	17.35	10.25	1.58	0.00	0.00	0.00	0.79
spinal cord, adult, donor10258	10369-105F9	69.18	21.45	0.00	2.08	0.00	0.00	1.38	0.00
spinal cord, fetal, donor1	10056-101H2	102.45	29.27	5.49	4.27	0.61	0.61	0.61	3.05
spinal cord, newborn, donor10223	10359-105E8	124.91	9.18	4.13	5.51	2.30	1.84	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	48.09	7.17	1.94	0.30	0.00	0.30	0.15	0.00
spleen, adult, pool1	10025-101D7	200.00	0.99	12.89	0.66	0.00	0.00	0.00	0.77
spleen, fetal, pool1	10044-101F8	159.55	2.15	10.65	0.48	0.16	0.08	0.00	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	187.15	0.00	8.90	0.10	0.72	0.00	0.00	0.52
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	75.38	3.04	1.52	0.00	0.00	0.00	0.19	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	81.07	9.44	1.75	3.49	2.45	0.00	0.35	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	66.85	0.00	1.95	0.00	0.39	0.00	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	133.72	1.13	4.28	0.00	0.11	0.00	0.00	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	99.97	5.93	2.12	1.69	0.42	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	70.65	4.23	2.54	0.00	0.42	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	81.17	8.54	0.00	1.07	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	85.45	2.28	2.28	1.14	0.00	0.00	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	162.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	122.55	15.37	4.98	0.42	0.21	0.00	0.21	0.42
substantia nigra, adult, donor10258	10371-105G2	76.55	7.76	2.07	2.07	0.00	0.52	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	54.41	5.65	1.41	3.53	0.71	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	96.06	10.78	2.98	0.92	0.00	0.46	0.00	0.46
temporal lobe, adult, pool1	10031-101E4	115.54	25.35	3.48	3.05	0.85	0.34	0.51	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	106.84	96.87	0.71	14.25	2.14	2.14	1.42	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	107.69	69.01	0.88	10.99	1.76	0.88	0.88	2.20
tenocyte, donor1	11763-123H8	39.80	14.66	1.05	0.70	1.40	0.00	0.00	0.35
tenocyte, donor2	11765-123I1	37.01	9.16	0.76	0.00	0.38	0.00	0.00	0.38
tenocyte, donor3	11768-123I4	40.40	10.01	0.74	0.37	0.37	0.00	0.00	1.85
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	90.76	4.42	1.70	3.57	0.17	0.68	0.51	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	70.14	7.55	2.77	3.55	0.15	0.00	0.00	0.31
teratocarcinoma cell line:PA-1	10807-111A6	69.89	7.90	3.25	2.01	0.15	0.93	0.31	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	75.53	3.94	2.03	5.20	0.13	0.76	0.38	0.51
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	56.35	1.51	0.00	1.13	0.38	0.38	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	52.35	2.29	4.04	3.27	0.11	0.11	0.11	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	87.94	0.33	3.58	1.30	1.30	0.00	0.33	0.00
testis, adult, pool1	10026-101D8	59.70	10.20	1.29	1.72	0.43	0.11	0.00	0.11
testis, adult, pool2	10096-102C6	46.46	12.63	1.80	1.35	0.00	0.00	0.00	0.90
thalamus - adult, donor10196	10168-103B6	99.36	17.66	1.10	6.62	1.10	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	115.96	21.10	4.53	1.41	0.78	0.16	0.00	0.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	76.98	7.70	0.00	3.08	0.00	1.54	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	32.61	7.74	1.15	1.32	0.82	0.82	0.33	0.00
thalamus, newborn, donor10223	10366-105F6	44.30	22.44	1.15	8.63	1.15	0.00	0.00	0.00
throat, adult	10209-103G2	65.16	3.00	0.75	1.25	1.00	0.50	0.00	0.00
throat, fetal, donor1	10061-101H7	50.28	16.15	2.13	5.18	0.00	0.00	0.30	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	43.72	7.95	0.99	1.39	0.00	0.00	0.20	0.00
thymus, adult, pool1	10027-101D9	178.65	1.29	12.92	0.30	0.70	0.10	0.10	0.10
thymus, fetal, pool1	10043-101F7	166.66	2.18	12.16	0.73	0.21	0.10	0.10	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	58.90	3.99	0.80	0.53	0.40	0.00	0.00	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	39.11	2.37	0.84	0.28	0.28	0.00	0.00	0.28
thyroid, adult, pool1	10028-101E1	88.18	2.61	1.87	0.47	0.09	0.00	0.00	0.28
thyroid, fetal, donor1	10060-101H6	62.22	6.86	1.58	0.00	0.00	0.53	0.00	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	64.67	9.24	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	49.54	3.02	1.16	1.63	0.00	0.00	0.23	0.00
tongue, fetal, donor1	10059-101H5	40.59	12.61	1.18	4.34	0.39	0.39	0.00	0.00
tonsil, adult, pool1	10047-101G2	198.85	3.21	11.32	0.80	0.20	0.10	0.00	0.10
trachea, adult, pool1	10029-101E2	97.42	2.86	4.25	0.41	0.33	0.08	0.16	0.08
trachea, fetal, donor1	10058-101H4	53.47	3.08	2.69	1.15	0.38	0.00	0.00	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	53.85	7.79	0.00	1.42	0.35	0.00	0.35	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	85.00	6.48	1.52	4.66	0.41	0.51	0.10	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	53.59	5.17	0.63	0.94	0.16	0.00	0.00	0.31
tridermal teratoma cell line:HGRT	10694-109G1	51.37	9.51	0.00	1.90	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	41.14	2.45	1.02	0.93	0.00	0.08	0.00	0.00
umbilical cord, fetal, donor1	10057-101H3	45.90	8.35	2.09	2.09	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	95.21	9.56	2.05	1.37	0.00	0.17	0.00	0.17
uterus, fetal, donor1	10055-101H1	56.82	10.75	2.56	1.02	1.02	0.00	0.00	0.00
vagina, adult	10204-103F6	55.57	1.29	0.65	0.00	0.00	0.00	0.00	0.00
vein, adult	10191-103E2	140.29	1.97	7.45	0.44	0.44	0.00	0.00	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	106.55	1.60	7.21	0.00	0.27	0.00	0.00	0.00